Six systems, one cumulative test. The full guide — exam mechanics, all six units, cross-system integration, a 126-card drill deck, and 30 scored applied items with distractor logic.
Heaviest and least-familiar material first, while capacity is highest and there's still time to patch what breaks. Tick blocks as you finish them — the day you're on is highlighted automatically. Sleep is consolidation, not lost study time.
U7 is the largest unit and carries your biggest gap. Front-load it.
The AKI/CKD block is the single biggest content gap in your files.
Your strongest existing material. Verification day plus four gap-fills.
Most of this unit is new. Two crisis discriminators to make automatic.
No new content. Interleaved retrieval beats blocked review.
The scaffolding that carried Exam 1, plus the two things a six-unit cumulative test adds: cross-system stems, and the expected-vs-unexpected filter that lets you answer correctly on content you don't recognize.
HESI scores 0–1500. 850 = acceptable, 900 = recommended. Your gradebook conversion ≈ HESI score × 0.09 (0–99.99 scale) — 1062 converted to roughly 95.6. NGN item types (bow-tie, matrix/trend, drag-and-drop, unfolding case studies) count in the scored total, not as unscored pilots (Evolve RN HESI Implementation Guide, 2024; Nightingale/CliffsNotes HESI results, 2025). HESI is validated as an NCLEX predictor, which is why it weights application over recall (NursingTip, 2025).
Stem vocabulary that signals a priority item: first, initial, priority, most important, immediate, requires immediate intervention, warrants notification, best indicates, would most concern the nurse.
Exam 1 tested four units that shared one substrate (fluids, acid-base, peri-op, respiratory). Exam 2 tests six systems that collide. HESI exploits this three ways:
(a) Cross-system stems. The patient has a renal problem and a cardiac consequence. The question is which one you address. → CKD patient with K⁺ 6.4 and peaked T waves: the answer is cardiac (stabilize the myocardium), not renal.
(b) Same finding, different meaning by system. "New confusion" is delirium from UTI (U8), hepatic encephalopathy (U6), hypoxia (↩U4), hyponatremia from TURP syndrome (U8) or carbamazepine (U10), or digoxin toxicity (U7). The distinguishing detail is always in the stem — find it before you answer.
(c) Drug collisions. One patient, two units, one contraindication. PDE-5 inhibitor + nitrate. ARNI + ACEi. Enzyme-inducing AED + oral contraceptive. Aminoglycoside + loop diuretic (double ototoxicity, ↩U4 + U7).
On a six-unit exam you will not always know the disease cold. You can still get the item right by asking: given this diagnosis, is this finding expected or unexpected?
| Diagnosis | EXPECTED (do not panic) | UNEXPECTED (this is the answer) |
|---|---|---|
| Post-op lap chole | Referred right shoulder pain (CO₂) | Fever + RUQ pain + jaundice |
| Post-TURP | Pink-tinged irrigation return | Bright red with clots; ↓Na⁺ + confusion |
| Ileostomy | Liquid output | No output + distension + cramping |
| Cirrhosis | Spider angiomas, jaundice | Asterixis, hematemesis, cloudy ascitic fluid |
| Rifampin (↩U4) | Orange-red urine | Jaundice, RUQ pain |
| New AV fistula | Thrill and bruit | Absent thrill; cool/numb hand |
| Seizure patient | Postictal drowsiness ~30 min | Seizure ≥5 min; no recovery between |
| Dialysis session | 2–3 kg weight loss | Headache, N/V, confusion mid-run (disequilibrium) |
Read the stem. Judge each option independently. Common HESI SATA architecture: 3 correct, 2 wrong — but never assume. The two most frequent wrong-option flavors: - The plausible-but-contraindicated (antidiarrheal in C. diff; heat on appendicitis; iron in thalassemia; BP cuff on the fistula arm). - The right action at the wrong time (ambulate a patient who is currently hypotensive; teach a patient who is currently in pain).
HESI threads scope-of-practice through every exam. Same rules, new patients:
Rule: delegate the stable, routine, predictable. Keep the unstable, novel, judgment-dependent.
Double time means the correct approach is not to go faster — it's to run the full chain on every item: 1. Read the stem twice. Identify the actual question (first action? highest priority? which to report?). 2. Name the system(s) in play and the phase of illness. 3. Cover the options. Predict your answer. 4. Uncover. Eliminate by the priority tree, not by feel. 5. On SATA, re-read each option against the stem individually.
Budget: ~2 minutes per standard item, ~4 for NGN cases. You will finish with time left.
This silently underlies about a third of the exam. Write it out three times before Saturday.
| Value | Normal | HESI red flag |
|---|---|---|
| Potassium (K⁺) | 3.5–5.0 mEq/L | >6.0 = peaked T waves → cardiac arrest. <3.0 = dysrhythmia + digoxin toxicity |
| Sodium (Na⁺) | 135–145 mEq/L | <120 or rapid shift = seizure / cerebral edema. Correct slowly (osmotic demyelination) |
| Calcium (Ca²⁺) | 8.5–10.5 mg/dL | Low → Trousseau/Chvostek, tetany, laryngospasm, seizure. High → dysrhythmia, stones |
| Magnesium (Mg²⁺) | 1.5–2.5 mEq/L | Low → torsades, refractory hypokalemia. High (renal) → ↓reflexes, resp. depression |
| pH | 7.35–7.45 | <7.35 acidosis / >7.45 alkalosis |
| PaCO₂ | 35–45 mmHg | Respiratory parameter (acid) |
| HCO₃⁻ | 22–26 mEq/L | Metabolic parameter (base) — the kidney is the metabolic compensator |
| PaO₂ | 80–100 mmHg | <60 = respiratory failure |
| SpO₂ | 95–100% (88–92% CO₂ retainers) | Trend > single number |
| Value | Normal | Why it matters |
|---|---|---|
| BUN | 10–20 mg/dL | ↑ in renal failure, dehydration, GI bleed, high protein, steroids |
| Creatinine | 0.6–1.2 mg/dL | Most specific renal marker. Doubling ≈ 50% GFR loss |
| BUN:Cr ratio | ~10–20:1 | >20:1 = prerenal (dehydration, ↓perfusion, GI bleed). ~10–15:1 = intrarenal |
| eGFR | >90 mL/min/1.73m² | CKD staging: G3a 45–59 · G3b 30–44 · G4 15–29 · G5 <15 = ESRD |
| Phosphorus | 2.5–4.5 mg/dL | ↑ in CKD (inverse of Ca²⁺); ↓ in refeeding syndrome |
| Troponin I/T | <0.04 ng/mL (assay-dependent) | Most specific cardiac marker. Rises 3–4 h, peaks 12–24 h, stays 10–14 d |
| CK-MB | 0–3% of total CK | Rises 4–6 h, peaks 18 h, returns 48–72 h — useful for re-infarction |
| BNP | <100 pg/mL | >100 supports HF; >400 strongly suggestive |
| Hemoglobin | M 14–18 / F 12–16 g/dL | <7 typical transfusion threshold in stable patients |
| Hematocrit | M 42–52% / F 37–47% | ≈ 3 × Hgb |
| MCV | 80–100 fL | <80 microcytic (iron) · >100 macrocytic (B12/folate) |
| WBC | 5,000–10,000/mm³ | ANC <500 = severe neutropenia → protective precautions |
| Platelets | 150,000–450,000 | <50k trauma bleed · <20k spontaneous · <10k critical |
| INR | 0.8–1.1 (therapeutic 2–3, mechanical valve 2.5–3.5) | Warfarin monitoring; ↑ in liver failure |
| aPTT | 30–40 sec (therapeutic 1.5–2.5× control) | Heparin monitoring |
| D-dimer | <0.5 mcg/mL | Sensitive not specific — rules PE/DVT out; ↑↑ in DIC |
| Ammonia | 15–45 mcg/dL | ↑ in hepatic encephalopathy |
| Albumin | 3.5–5.0 g/dL | ↓ in liver failure, malnutrition, nephrotic syndrome |
| Total bilirubin | 0.3–1.0 mg/dL | ↑ → jaundice (visible ~2–3 mg/dL) |
| AST / ALT | AST 10–40 · ALT 7–56 U/L | AST:ALT >2:1 suggests alcohol-related liver disease |
| Amylase | 30–110 U/L | ↑ pancreatitis (less specific) |
| Lipase | 0–160 U/L | More specific for pancreatitis; 3× ULN is diagnostic |
| Digoxin | 0.5–2.0 ng/mL (HF target 0.5–0.9) | Narrow index. Hypokalemia potentiates toxicity |
| Phenytoin | 10–20 mcg/mL | Narrow index. Nystagmus → ataxia → confusion as it climbs |
| Carbamazepine | 4–12 mcg/mL | Watch Na⁺ and CBC |
| Valproate | 50–100 mcg/mL | Watch LFTs, ammonia, platelets |
| Urine specific gravity | 1.005–1.030 | ↑ concentrated (dehydration, SIADH) · ↓ dilute (DI, renal failure) |
| PSA | <4 ng/mL | Draw before DRE; ↑ with BPH, prostatitis, cancer |
| Serum osmolality | 275–295 mOsm/kg | Pairs with Na⁺ for the hypo/hypernatremia picture |
Two numbers to hold above all others on this exam: K⁺ 6.0+ with ECG changes, and Na⁺ under 120. They cross four of your six units and they are almost always the answer to "which finding requires immediate intervention."
Your existing tables preserved. The counter on each unit shows how many blueprint additions and red flags it contains — + NEW marks content that wasn't in your working files, so you can skip anything your syllabus excludes.
Through-line: the gut is a tube with two failure modes — inflammation and motility. Every U5 topic is one or the other. Anchor: your 26-year-old woman with Crohn's mid-flare.
| Crohn's | Ulcerative Colitis | |
|---|---|---|
| Pattern / depth | Skip lesions, transmural, mouth→anus | Continuous, mucosa only, colon + rectum |
| Stool | Often non-bloody, steatorrhea | Bloody / mucoid (hallmark) |
| Complications | Fistulas, strictures, abscess, obstruction, B12 malabsorption | Toxic megacolon, perforation, ↑colon cancer |
| Surgery | Not curative (recurs at anastomosis) | Curative (colectomy) |
Why the table works: transmural → tunnels → fistulas/strictures. Mucosa-only → surface bleeding → bloody stool. Confined to colon → remove colon → cured.
↩ Flare cross-link: profuse diarrhea → loses bicarbonate-rich fluid + K⁺ → hypovolemia + hypokalemia + metabolic ACIDOSIS. Priority assessment is fluid/electrolyte status. Crohn's → B12 deficiency because the terminal ileum (B12's only absorption site) is the most common Crohn's location.
🚩 TOXIC MEGACOLON — UC patient with a rigid, distended, silent abdomen + fever + tachycardia. → Stop antidiarrheals, NPO, NG decompression, notify surgeon. Perforation is imminent. A silent abdomen after hyperactive sounds is always ominous.
| Class | Drugs | Pearl |
|---|---|---|
| 5-ASA | Sulfasalazine, mesalamine | Works in UC, NOT Crohn's. Folic acid supplement, push fluids, sulfa allergy caution |
| Corticosteroids | Prednisone, budesonide | Flares only — not maintenance. Taper, never stop abruptly. Hyperglycemia, infection, osteoporosis |
| Immunomodulators | Azathioprine, 6-MP, methotrexate | Steroid-sparing; slow onset (weeks–months); monitor CBC + LFTs. MTX teratogenic |
| Biologics | Infliximab, adalimumab, vedolizumab, ustekinumab | Screen TB + hepatitis B before starting ↩U4. Infection + malignancy risk; infusion reactions |
Surgery: UC → total colectomy is curative (ileostomy or J-pouch). Crohn's → palliative and bowel-sparing (repeated resections → short-bowel syndrome).
GERD = symptomatic reflux. Barrett's = chronic-GERD-induced intestinal metaplasia = premalignant (→ esophageal adenocarcinoma), usually asymptomatic, diagnosed by endoscopy + biopsy with surveillance.
Alarm features → endoscopy now: dysphagia, odynophagia, unintentional weight loss, GI bleeding/anemia, persistent vomiting. Teaching: HOB elevated 6–8 inches (blocks, not just pillows), no recumbency for 2–3 h after meals, smaller meals, weight loss, smoking cessation, avoid triggers (caffeine, chocolate, peppermint, alcohol, fatty/spicy). Aspiration is the safety risk — this is why positioning is a priority, not comfort.
| Class | Drugs | Pearl |
|---|---|---|
| Antacids | CaCO₃, aluminum/magnesium hydroxide | Neutralize existing acid. Aluminum → constipation; magnesium → diarrhea. Separate from other drugs by 1–2 h |
| H2RAs | Famotidine | ↓acid secretion; moderate effect; onset faster than PPI |
| PPIs | Omeprazole, pantoprazole, esomeprazole | Most effective. Take 30–60 min BEFORE the first meal. Full effect 1–4 days. Standard for Barrett's. Long-term: ↓B12/Mg/Ca, fracture, C. diff risk |
| Prokinetic | Metoclopramide | ↑gastric emptying + LES tone. Boxed warning: tardive dyskinesia — limit to ≤12 weeks |
Chronic, relapsing metabolic disease with strong genetic and environmental determinants — not a willpower deficit. Weight stigma in healthcare independently worsens outcomes by delaying care-seeking and shifting diagnostic attention away from the presenting complaint.
BMI: overweight 25–29.9 · Class I 30–34.9 · Class II 35–39.9 · Class III ≥40. Pair with waist circumference; BMI misclassifies at the individual level. Comorbidities: T2DM, HTN, dyslipidemia, CAD, HF, OSA, MASLD, OA, GERD, obstetric risk, several cancers.
| Class | Drug | Pearl |
|---|---|---|
| Noradrenergic anorexiant | Phentermine | Appetite suppression; ↑HR/BP, insomnia; contraindicated in CVD, short-term |
| Lipase inhibitor | Orlistat | Blocks fat absorption; oily stools, flatus, fat-soluble vitamin (A/D/E/K) malabsorption — supplement at a separate time |
| Combination | Naltrexone–bupropion | Central; monitor BP, mood, seizure threshold |
| Incretin (current standard) | Semaglutide, tirzepatide | ~15–22% weight loss + cardiovascular/renal benefit. GI effects (N/V, constipation), pancreatitis caution, boxed warning: medullary thyroid carcinoma/MEN2, gastroparesis — hold before anesthesia |
Bariatric surgery (BMI ≥40, or ≥35 with comorbidity): Roux-en-Y (restrictive + malabsorptive → dumping syndrome, B12/iron/calcium/thiamine deficiency), sleeve gastrectomy (most common), adjustable band, BPD/DS. Post-op priorities: ① airway (OSA is common — HOB up, CPAP), ② VTE prophylaxis + early ambulation, ③ anastomotic leak — tachycardia, fever, abdominal or left shoulder pain, restlessness = emergency, ④ staged diet advancement, ⑤ small frequent meals, no fluids with meals (30 min before/after), ⑥ dumping syndrome teaching (avoid simple sugars; lie down after eating), ⑦ lifelong vitamin supplementation.
Constipation: slowed transit. Causes: low fiber/fluid, immobility, opioids (tolerance never develops — prophylax), anticholinergics, iron, hypothyroidism, hypercalcemia, hypokalemia. Complications: fecal impaction (paradoxical liquid stool leaking around the mass — do not treat as diarrhea), obstruction. Any patient started on opioids gets a prophylactic stimulant laxative. Stool softener alone is insufficient.
Diarrhea: ↩ priority complication = dehydration + hypokalemia + metabolic acidosis. 🚩 Red flag combination: bloody diarrhea + fever + recent antibiotics = C. difficile. - NO antimotility agents — retaining toxin precipitates toxic megacolon. - Soap-and-water hand hygiene — alcohol gel does not kill spores. - Contact precautions, dedicated equipment, bleach-based cleaning. - Treatment: oral vancomycin or fidaxomicin (metronidazole is now second-line); fecal microbiota transplant for recurrence.
| Class | Drug | Pearl |
|---|---|---|
| Bulk-forming | Psyllium, methylcellulose | Safest, first-line. Requires adequate fluid or it worsens obstruction. Slow onset |
| Stimulant | Bisacodyl, senna | Fast; standard for opioid-induced constipation |
| Osmotic | PEG, lactulose, magnesium citrate | Lactulose also treats hepatic encephalopathy (traps ammonia) |
| Softener / lubricant | Docusate; mineral oil | Mineral oil → ↓fat-soluble vitamins, aspiration risk — never at bedtime |
| Antidiarrheal | Loperamide, diphenoxylate–atropine | NEVER in infectious diarrhea or C. diff |
Through-line: the acute abdomen races obstruction/inflammation → ischemia → perforation → peritonitis → sepsis. Every U6 topic occupies a point on that line. Your job is to name the stage. Anchor: your 68-year-old post-op adhesion SBO.
| SBO | LBO | |
|---|---|---|
| Onset | Rapid | Gradual |
| Vomiting | Early, profuse (often bilious/feculent) | Late or absent |
| Distension | Moderate | Marked |
| Constipation/obstipation | Later | Early |
| #1 cause | Adhesions (hernia #2) | Colorectal cancer (volvulus, diverticular stricture) |
Four cardinal symptoms: pain, vomiting, distension, obstipation. Bowel sounds: high-pitched/hyperactive early → absent late. Absent is worse. Simple vs strangulated: strangulation = blood supply lost = fever, tachycardia, leukocytosis, ↑lactate, peritoneal signs, constant (not colicky) pain → surgical emergency. CT with contrast = gold standard. Management: NPO, NG decompression, IV fluid + electrolyte replacement (the priority), analgesia, surgery if complete or strangulated.
↩ NG suction → metabolic ALKALOSIS + hypokalemia + hypochloremia — loses acid from above. The mirror image of diarrhea's acidosis. This contrast is a near-guaranteed item.
"If the gut works, use it." Enteral is preferred — maintains mucosal integrity, fewer infections, cheaper.
TPN safety: central line required (hypertonic); dedicated line — no piggybacking; monitor glucose q4–6h; strict aseptic technique; daily weights and electrolytes; never stop abruptly → hang D10W if the next bag is unavailable (rebound hypoglycemia).
🚩 REFEEDING SYNDROME: in a chronically malnourished patient, reintroducing carbohydrate drives phosphorus, potassium, and magnesium into cells → cardiac arrhythmia, respiratory failure, death. Start slow, advance slowly, replete electrolytes before and during, monitor daily. Highest-risk: anorexia nervosa, alcohol use disorder, prolonged NPO, post-bariatric.
Cholelithiasis = stones. Cholecystitis = inflammation, usually obstructive. Classic risk profile: female, forties, fertile, higher body weight, fair — plus rapid weight loss, pregnancy, oral contraceptives, Native American and Hispanic ancestry. Presentation: RUQ pain radiating to the right shoulder/scapula, worse after fatty meals, N/V, fever. Murphy's sign (inspiratory arrest on RUQ palpation) = cholecystitis. RUQ ultrasound = test of choice. Laparoscopic cholecystectomy = gold standard. Post-op: referred shoulder pain from residual CO₂ is expected — ambulate, position; report fever, jaundice, clay stools, dark urine. Choledocholithiasis/cholangitis: stone in the common bile duct → Charcot's triad (RUQ pain, fever, jaundice) → ERCP. Add hypotension + confusion = Reynolds' pentad = emergency.
Mucosal erosion through the muscularis mucosae. Two causes: H. pylori (#1) and NSAIDs. Spicy food and stress aggravate symptoms; they do not cause ulcers.
| Gastric ulcer | Duodenal ulcer | |
|---|---|---|
| Pain timing | 30–60 min after eating; food worsens | 2–3 h after eating / empty stomach; food relieves; nocturnal |
| Weight | Often loss (avoids eating) | Often stable or gain |
| Malignancy risk | Higher — biopsy | Rare |
Complications: hemorrhage (hematemesis, coffee-ground emesis, melena), perforation (sudden severe pain, board-like rigid abdomen → peritonitis), gastric outlet obstruction. EGD = definitive diagnosis.
⚠ H. pylori regimens — know both: - The regimen your course materials teach (and HESI likely tests): clarithromycin triple therapy — PPI + clarithromycin + amoxicillin × 14 days. - The current standard of care: the 2024 ACG guideline removed clarithromycin triple therapy as a first-line option for treatment-naïve patients because of rising clarithromycin resistance, and preferred optimized bismuth quadruple therapy — PPI + bismuth + tetracycline + metronidazole × 14 days. Rifabutin triple therapy and potassium-competitive acid blocker (vonoprazan) dual therapy are the recommended empiric alternatives in patients without penicillin allergy. - Exam strategy: if the answer choices contain triple therapy and not quadruple, choose triple. If both appear, choose bismuth quadruple. Confirm eradication after treatment either way.
Other PUD drugs: sucralfate (forms a protective barrier — give on an empty stomach, separate from other drugs by 2 h); misoprostol (NSAID-ulcer prophylaxis — contraindicated in pregnancy, causes uterine contractions).
Appendicitis: periumbilical pain migrating to RLQ at McBurney's point. Rebound tenderness, Rovsing's (LLQ palpation → RLQ pain), psoas and obturator signs, anorexia (nearly universal), low-grade fever, ↑WBC with left shift. 🚩 Sudden relief of pain = RUPTURE, not improvement. Expect rebound, rigidity, and rising fever next. The three DON'Ts: no heat, no laxatives, no enemas — all increase perforation risk. Withholding analgesia is outdated; pain control does not obscure the diagnosis.
Peritonitis (the shared endpoint): rigid, board-like abdomen, diffuse pain, rebound, absent bowel sounds, fever, tachycardia, hypotension, shallow rapid breathing. The patient lies motionless with knees flexed — colic patients writhe. That posture difference is a HESI discriminator. Emergency management: NPO, NG decompression, aggressive IV fluid resuscitation, broad-spectrum IV antibiotics, surgical source control, semi-Fowler's to localize drainage.
Diverticular disease: diverticulosis = asymptomatic outpouchings (low-fiber, Western diet). Diverticulitis = inflamed/microperforated → LLQ pain, fever, ↑WBC, altered bowels. CT is diagnostic; colonoscopy is contraindicated during acute inflammation (perforation risk) — do it 6–8 weeks after resolution. The diet reversal HESI loves: high-fiber to PREVENT, low-fiber/bowel rest during a FLARE. The old nuts-and-seeds restriction is not evidence-based.
Shared antibiotic theme for intra-abdominal infection: gram-negative + anaerobe coverage — metronidazole + a fluoroquinolone or ceftriaxone; piperacillin–tazobactam for severe disease.
Autodigestion of the pancreas by prematurely activated enzymes. Two causes account for ~80%: gallstones and alcohol. Also hypertriglyceridemia, post-ERCP, hypercalcemia, drugs (thiazides, valproate, GLP-1 agonists), trauma.
Presentation: severe, constant epigastric pain radiating straight through to the back, relieved by leaning forward or curling into a fetal position — the opposite of peritonitis' motionless supine posture. Nausea/vomiting, fever, tachycardia, hypoactive bowel sounds. 🚩 Cullen's sign (periumbilical ecchymosis) and Grey Turner's sign (flank ecchymosis) indicate hemorrhagic pancreatitis — grave prognosis.
Labs: lipase (more specific) and amylase elevated ≥3× upper limit of normal; ↑WBC, ↑glucose, ↑bilirubin, ↓calcium (fat saponification → watch for Chvostek/Trousseau ↩), ↑triglycerides, ↓Hct if hemorrhagic.
Management: 1. Aggressive IV fluid resuscitation — lactated Ringer's preferred; this is the single highest-impact intervention. 2. Pain control — opioids; the old "avoid morphine because of sphincter of Oddi spasm" teaching is not evidence-based. 3. NPO initially, then early enteral feeding (within 24–72 h) — enteral is now preferred over TPN when tolerated. 4. NG suction only for ileus or intractable vomiting. 5. Monitor for hypocalcemia, hyperglycemia, hypovolemic shock, ARDS ↩U4, pseudocyst, necrosis, and multi-organ failure. 6. Position: side-lying with knees flexed, or upright leaning forward.
Chronic pancreatitis: steatorrhea, weight loss, malabsorption, secondary diabetes. Pancreatic enzyme replacement WITH every meal and snack, fat-soluble vitamins, absolute alcohol cessation, smoking cessation.
Causes: alcohol-related liver disease, MASLD (metabolic dysfunction–associated steatotic liver disease, formerly NAFLD), chronic hepatitis B/C.
Portal hypertension produces the whole picture: esophageal/gastric varices, splenomegaly (→ thrombocytopenia), ascites, caput medusae, hemorrhoids. Other findings: jaundice, pruritus, spider angiomas, palmar erythema, gynecomastia/testicular atrophy, fetor hepaticus, clubbing. Labs: ↑bilirubin, ↑AST/ALT (AST:ALT >2:1 suggests alcohol), ↓albumin (→ edema/ascites), ↑INR (↓clotting factor synthesis), ↑ammonia, ↓platelets, ↓Na⁺ (dilutional).
🚩 Bleeding esophageal varices — the U6 cardiac-arrest-equivalent. Massive hematemesis, hypotension, tachycardia. Priority: ABC first — airway protection against aspiration, two large-bore IVs, type and cross, volume + blood, octreotide infusion, IV antibiotics (prophylaxis reduces mortality), endoscopic band ligation, balloon tamponade as a bridge, TIPS for refractory bleeding. Prevention: non-selective beta-blocker (propranolol/nadolol), avoid straining/Valsalva/NSAIDs/alcohol, no rough foods.
Ascites: sodium restriction, spironolactone + furosemide, daily weights and abdominal girth, paracentesis — have the patient void immediately before, position upright, monitor for hypotension after large-volume removal, give albumin with >5 L removal. 🚩 Spontaneous bacterial peritonitis: fever, abdominal pain, or new confusion alone in a patient with ascites → diagnostic paracentesis (PMN >250 cells/mm³) → antibiotics. Low threshold to suspect.
🚩 Hepatic encephalopathy: ↑ammonia → asterixis (flapping tremor), personality change, confusion, day-night reversal → coma. Lactulose titrated to 2–3 soft stools per day — do not hold it because the patient is having stools; that is the therapy. Add rifaximin for recurrence. Identify precipitants: GI bleed, infection, constipation, dehydration, hypokalemia, sedatives. Protein is no longer restricted — malnutrition worsens outcomes.
Bleeding precautions throughout: soft toothbrush, electric razor, no IM injections, avoid NSAIDs/aspirin, monitor for occult bleeding.
| Upper GI bleed (above ligament of Treitz) | Lower GI bleed | |
|---|---|---|
| Presentation | Hematemesis, coffee-ground emesis, melena (black, tarry) | Hematochezia (bright red per rectum) |
| Causes | PUD, varices, Mallory–Weiss tear, gastritis, malignancy | Diverticular, angiodysplasia, hemorrhoids, IBD, cancer |
| Lab clue | ↑BUN (digested blood protein) with normal creatinine | BUN typically normal |
Priority sequence: ABC → hemodynamic assessment (tachycardia and narrowing pulse pressure precede hypotension) → two large-bore IVs → type and cross → isotonic fluid then blood → NPO → IV PPI infusion → octreotide if varices suspected → EGD/colonoscopy. ↩ Shock Index (HR ÷ SBP): ≥0.9 refer, ≥1.4 urgent — catches the compensating patient before the blood pressure falls.
| Ileostomy | Colostomy | |
|---|---|---|
| Output | Liquid to pasty, continuous | Semi-formed to formed by location (ascending liquid → sigmoid formed) |
| Risks | Dehydration + electrolyte loss; enzyme-rich effluent excoriates skin | Constipation; odor/gas |
| Notes | No laxatives; chew thoroughly (obstruction risk from high-fiber foods) | Sigmoid colostomy may be irrigated for regulation |
🚩 Stoma assessment (RN, not delegated on initial assessment): - Pink to beefy red, moist = healthy. Slight bleeding when cleaned is normal. - Pale = anemia or poor perfusion. - Dusky, purple, or black = ischemia/necrosis = notify the surgeon immediately. - Expect mild edema for the first several days.
Appliance: cut the barrier ~1/8 inch larger than the stoma; empty the pouch at one-third to one-half full; change every 3–7 days or if leaking; skin barrier powder/paste for excoriation. Report no output plus distension and cramping (obstruction).
Through-line: the plumbing (HTN, HF, PAD, ACS, dysrhythmias) versus the fluid inside it (anemias, platelets, coagulation). Efficiency note: ACEi/ARB, beta-blockers, and diuretics appear in HTN and HF and CKD. Learn them once in 7.1 and reuse them three times. Anchors: your HTN→HF trajectory patient, the menorrhagia-anemia patient, the diabetic-smoker with PAD.
BP = cardiac output × systemic vascular resistance; RAAS is the long-term regulator. "The silent killer."
Categories (2025 AHA/ACC, unchanged from 2017): Normal <120/<80 · Elevated 120–129/<80 · Stage 1 130–139 or 80–89 · Stage 2 ≥140 or ≥90. Universal treatment goal: <130/80. + NEW 2025 guideline updates worth 60 seconds: the PREVENT risk calculator replaces the Pooled Cohort Equations and drives the treat-or-wait decision in stage 1; first-line agent selection is now race-neutral; stage 2 starts on two agents in a single-pill combination; an MRA is added for resistant hypertension; and hypertensive emergency goes to the ICU. First-line classes remain thiazide, dihydropyridine CCB, and ACEi/ARB.
Crisis: urgency (>180/120, no target-organ damage → oral agents, outpatient) vs emergency (>180/120 with organ damage: encephalopathy, stroke, MI, aortic dissection, AKI, papilledema, eclampsia → IV nicardipine, labetalol, clevidipine, nitroprusside). 🚩 The rule: lower MAP by no more than ~25% in the first hour. Faster drops cause watershed stroke, MI, and renal infarction. (Exception: aortic dissection — lower fast and hard.)
| Class | Mechanism | Signature effects / nursing |
|---|---|---|
| ACEi (-pril) | Blocks angiotensin I→II | Dry cough, angioedema, hyperkalemia, teratogenic, ↑Cr acutely (acceptable up to ~30%) |
| ARB (-sartan) | Blocks AT-II receptor | No cough; hyperkalemia, teratogenic. Never combine with an ACEi |
| CCB, dihydropyridine (-dipine) | Arterial vasodilation | Peripheral edema, headache, reflex tachycardia, gingival hyperplasia |
| CCB, non-DHP (verapamil, diltiazem) | ↓HR + contractility | Bradycardia, constipation, heart block; avoid combining with a beta-blocker |
| Thiazide (HCTZ, chlorthalidone) | ↓Na⁺ reabsorption, distal tubule | Hypokalemia, hyperglycemia, hyperuricemia (gout), hypercalcemia, photosensitivity |
| Loop (furosemide, bumetanide) | ↓Na⁺ reabsorption, loop of Henle | Hypokalemia, ototoxicity (worse with aminoglycosides ↩U4), hypovolemia, hypomagnesemia |
| K⁺-sparing / MRA (spironolactone, eplerenone) | Blocks aldosterone | Hyperkalemia, gynecomastia (spironolactone), survival benefit in HF |
| Beta-blocker (-olol) | ↓HR, ↓renin | Masks hypoglycemia, bronchospasm (non-selective), fatigue; hold if HR <60; never stop abruptly (rebound tachycardia/ischemia) |
| Central alpha-2 agonist (clonidine) | ↓sympathetic outflow | Rebound hypertension if stopped abruptly; sedation, dry mouth |
| Alpha-1 blocker (-osin) | Peripheral vasodilation | First-dose syncope — give at bedtime; also treats BPH →U8 |
| Direct vasodilator (hydralazine, minoxidil) | Arterial relaxation | Reflex tachycardia, fluid retention, lupus-like syndrome (hydralazine) |
HFrEF (EF ≤40%, systolic — problem pumping) vs HFpEF (EF ≥50%, diastolic — problem filling). Mildly reduced 41–49%.
LEFT = Lungs. Dyspnea, orthopnea, paroxysmal nocturnal dyspnea, crackles, pink frothy sputum, S3, fatigue, nocturia. RIGHT = Rest of body. JVD, dependent edema, hepatomegaly, ascites, weight gain, anorexia/nausea from gut congestion. Left failure is the most common cause of right failure.
BNP >100 supports HF; >400 strongly suggestive. ↩ Hypervolemia from Exam 1 is the same assessment. Daily weights at the same time, same clothes, after voiding — report a gain of 2–3 lb in a day or ~5 lb in a week. This is the single most-tested HF teaching point.
🚩 Acute decompensation / flash pulmonary edema: severe dyspnea, orthopnea, pink frothy sputum, anxiety, crackles throughout. Priority: high Fowler's with legs dependent → oxygen → IV loop diuretic → nitrates → morphine (selective) → consider noninvasive ventilation. Airway and oxygenation before pharmacology.
| Drug | Pearl |
|---|---|
| ARNI (sacubitril–valsartan) | Cornerstone; the 2024 ACC pathway now prefers it over an ACEi/ARB rather than treating them as equivalent. Never with an ACEi — 36-hour washout (angioedema). Hyperkalemia, hypotension |
| Digoxin | 0.5–2.0 ng/mL (HF target 0.5–0.9). Hold if apical HR <60 (count a full minute). Hypokalemia potentiates toxicity. Toxicity: anorexia, N/V, visual halos/yellow-green vision, bradycardia, dysrhythmias. Antidote digoxin immune Fab. Symptom benefit only — no mortality benefit |
| SGLT2 inhibitor (dapagliflozin, empagliflozin) | Mortality benefit even in non-diabetics; genital mycotic infection, euglycemic DKA, volume depletion |
| MRA (spironolactone, eplerenone) | Survival benefit; hyperkalemia — monitor K⁺ and creatinine |
| Nesiritide | IV BNP analog for acute decompensated HF |
| Milrinone / dobutamine | IV inotropes for advanced/low-output HF |
| Ivabradine | SA-node modulator; for sinus rhythm with HR ≥70 despite maximal beta-blocker |
| Hydralazine + isosorbide dinitrate | Survival benefit, particularly in Black patients with HFrEF (per the 2022 AHA/ACC/HFSA guideline) |
The four pillars of HFrEF — ARNI/ACEi/ARB + beta-blocker + MRA + SGLT2 inhibitor — and the current emphasis is on getting all four started rapidly rather than sequentially maximizing one at a time.
Teaching: daily weights, sodium restriction (2–3 g), fluid restriction if hyponatremic, energy conservation, report weight gain/increasing edema/worsening dyspnea/orthopnea before it becomes an admission, annual influenza and pneumococcal vaccination ↩U4.
The spectrum:
| Trigger | ECG | Troponin | |
|---|---|---|---|
| Stable angina | Predictable exertion; relieved by rest or nitroglycerin | ST depression during pain only | Normal |
| Unstable angina | At rest, new, or increasing | ST depression / T inversion | Normal |
| NSTEMI | Rest | ST depression / T inversion | Elevated |
| STEMI | Rest | ST elevation | Elevated |
| Prinzmetal/vasospastic | Coronary spasm, often at rest/night | Transient ST elevation | Usually normal |
Classic presentation: crushing substernal chest pressure radiating to the left arm, jaw, or back; diaphoresis; nausea; dyspnea; sense of impending doom. 🚩 The atypical presentation HESI loves — women, older adults, and people with diabetes may present with NO chest pain: fatigue, dyspnea, indigestion, jaw/back/epigastric discomfort, nausea, or syncope. Autonomic neuropathy blunts the pain signal. Do not dismiss a diabetic woman with "indigestion."
Markers: troponin I/T is the most specific — rises 3–4 h, peaks 12–24 h, remains elevated 10–14 days. High-sensitivity assays detect earlier. CK-MB rises 4–6 h, peaks 18 h, normalizes 48–72 h — its value now is detecting re-infarction. Myoglobin rises first but is nonspecific.
Immediate management: 1. 12-lead ECG within 10 minutes of arrival/symptom report. 2. Aspirin 162–325 mg chewed — chewed, not swallowed whole, for rapid absorption. This is often the first pharmacologic action. 3. Oxygen only if SpO₂ <90% — routine oxygen in a normoxic patient is no longer recommended and may cause harm. 4. Nitroglycerin sublingual q5min ×3. Absolute contraindication: a PDE-5 inhibitor (sildenafil/tadalafil) in the preceding 24–48 h → catastrophic hypotension →U8. Also avoid in right-ventricular/inferior MI with hypotension (preload-dependent) and with SBP <90. 5. Morphine for refractory pain — may mask symptoms and is now a lower-tier recommendation. 6. Continuous cardiac monitoring, IV access, serial troponins.
Reperfusion: PCI is preferred — door-to-balloon ≤90 minutes (≤120 if transfer required). Fibrinolysis door-to-needle ≤30 minutes where PCI is unavailable; screen hard for bleeding contraindications (recent surgery, stroke, active bleeding, uncontrolled HTN). Ongoing: dual antiplatelet therapy (aspirin + clopidogrel/ticagrelor/prasugrel), high-intensity statin, beta-blocker, ACEi/ARB, cardiac rehabilitation.
🚩 Post-MI complications: dysrhythmias are the leading cause of death in the first hours; also cardiogenic shock, heart failure, papillary muscle rupture (new holosystolic murmur + acute pulmonary edema), ventricular free-wall rupture, pericarditis and Dressler's syndrome (weeks later).
Teaching: nitroglycerin storage (dark glass, replace q6 months, expect headache/tingling), call EMS if pain persists after the first dose rather than waiting for three, sexual activity generally safe when able to climb two flights of stairs — but never combine nitrates with a PDE-5 inhibitor.
Atrial fibrillation — irregularly irregular rhythm, no discernible P waves, variable ventricular response. Loss of atrial kick → ~20% drop in cardiac output. The lethal risk is atrial thrombus → embolic stroke. - Rate control: beta-blocker, non-DHP CCB, digoxin. - Rhythm control: amiodarone, flecainide, cardioversion, ablation. - Anticoagulation stratified by CHA₂DS₂-VASc (CHF, HTN, Age ≥75 = 2, Diabetes, Stroke/TIA = 2, Vascular disease, Age 65–74, Sex category female). - If AF has lasted >48 h or is of unknown duration: 3 weeks of anticoagulation before cardioversion, or a TEE to exclude thrombus first — cardioverting a clot into circulation causes stroke.
SVT — narrow complex, rate 150–250. Vagal maneuvers → adenosine rapid IV push with immediate flush (warn the patient about a brief asystolic pause and chest discomfort) → synchronized cardioversion if unstable.
Ventricular tachycardia — wide complex. With a pulse and stable: amiodarone. With a pulse and unstable: synchronized cardioversion. Pulseless VT or VF: defibrillate immediately + high-quality CPR + epinephrine. Asystole / PEA: CPR + epinephrine — do NOT shock. (Shocking asystole is a classic distractor.)
Bradycardia (symptomatic): atropine → transcutaneous pacing → dopamine or epinephrine infusion.
Blocks: 1st degree (PR >0.20, benign) · 2nd degree Type I/Wenckebach (progressive PR lengthening then a dropped beat) · 2nd degree Type II (dropped beats without warning — can progress abruptly) · 3rd degree/complete (P waves and QRS independent → pacemaker).
Pacemaker/ICD teaching: check pulse daily; no arm elevation above shoulder for 4–6 weeks; avoid strong magnetic fields, arc welding, MRI unless the device is MRI-conditional; hold a cell phone to the opposite ear; carry the device card; report hiccups or twitching (lead displacement), fever/redness at the site, dizziness or syncope; report ICD shocks.
| Drug | Monitor | Antidote / reversal | Nursing |
|---|---|---|---|
| Heparin (UFH) | aPTT 1.5–2.5× control; anti-Xa | Protamine sulfate | Monitor platelets (HIT); bleeding precautions |
| Enoxaparin (LMWH) | None routine (anti-Xa if renal/obese/pregnant) | Protamine (partial) | Subcutaneous, abdomen, do NOT expel the air bubble, do NOT aspirate or massage; rotate sites |
| Warfarin | INR 2–3 (2.5–3.5 mechanical valve); PT | Vitamin K (phytonadione); PCC/FFP for major bleed | Consistent — not zero — vitamin K intake; enormous interaction list; teratogenic; effect takes 3–5 days (bridge with heparin) |
| DOACs — apixaban, rivaroxaban (factor Xa); dabigatran (direct thrombin) | No routine monitoring | Andexanet alfa (Xa inhibitors); idarucizumab (dabigatran) | Renal dosing; do not open/crush dabigatran capsules; adherence is critical (short half-life) |
| Antiplatelets — aspirin, clopidogrel, ticagrelor, prasugrel | Platelet function if needed | None specific | Hold before surgery per protocol; GI upset/bleeding |
| Thrombolytics — alteplase, tenecteplase | Fibrinogen, bleeding | Aminocaproic acid; cryoprecipitate | Screen contraindications; minimize punctures; monitor neuro status |
Universal bleeding precautions: soft toothbrush, electric razor, no rectal temperatures or suppositories, no IM injections, avoid NSAIDs/aspirin unless prescribed, hold pressure longer after venipuncture, fall prevention, monitor for occult bleeding (stool, urine, gums, headache/neuro change).
Virchow's triad: venous stasis + endothelial injury + hypercoagulability. ↩U3 — this is why post-op patients ambulate. DVT: unilateral calf/thigh swelling, warmth, erythema, pain, ↑circumference. Do not massage the extremity. Diagnose with duplex ultrasound; D-dimer rules out. 🚩 PE ↩U4: sudden dyspnea, pleuritic chest pain, tachycardia, anxiety, hypoxemia, hemoptysis. Priority: oxygen and semi-Fowler's first, then notify, then anticoagulate. This is a breathing emergency before it is a clotting problem. Prevention: early ambulation, sequential compression devices, prophylactic anticoagulation, hydration.
Classify by MCV. Shared presentation: fatigue, pallor, dyspnea on exertion, tachycardia, dizziness.
| Anemia | Distinctive features | Management |
|---|---|---|
| Iron deficiency | Microcytic, hypochromic; pica, spoon nails (koilonychia), glossitis. Find the source — menorrhagia in premenopausal women, GI bleed/colon cancer in everyone else | Oral iron on an empty stomach with vitamin C; expect dark stools; liquid form through a straw (stains teeth); constipation; IV iron if intolerant |
| B12 / pernicious | Macrocytic + NEUROLOGIC symptoms (paresthesia, ataxia, ↓proprioception, cognitive change); absent intrinsic factor, gastric surgery, ileal disease ↩U5 | Lifelong B12 injections (oral fails without intrinsic factor). Neuro damage may be permanent if treatment is delayed |
| Folate | Macrocytic, NO neurologic symptoms | Folate; prevents neural tube defects — relevant to your U10 epilepsy-and-pregnancy content |
| Aplastic | Pancytopenia — all three cell lines | Transfusion, immunosuppression, hematopoietic cell transplant; neutropenic + bleeding precautions |
| Thalassemia | Genetic, chronic hemolysis, microcytic | Transfusion + iron chelation. Never give iron — these patients are iron-overloaded |
| Anemia of CKD →U8 | Normocytic; ↓erythropoietin | ESAs targeting Hgb 10–11 g/dL — not higher (↑thrombosis/stroke above target) + iron |
The B12-versus-folate discriminator is the neurologic exam. Both are macrocytic; only B12 damages nerves.
Autosomal recessive hemoglobin S. Deoxygenated HbS polymerizes → rigid sickled cells → vaso-occlusion + hemolysis. Triggers: hypoxia, dehydration, infection, cold, physical/emotional stress, acidosis, high altitude.
🚩 Vaso-occlusive (pain) crisis: severe pain in bones, joints, chest, abdomen, back. Management: PAIN IS THE PRIORITY — scheduled/PCA opioids at adequate doses, aggressive hydration, oxygen, warmth (never cold — cold causes vasoconstriction and worsens sickling), rest. Equity note that is also a test-taking cue: Black patients with sickle cell are systematically under-treated for pain, wait longer in emergency departments, and are more often labeled drug-seeking. On HESI, when the stem describes a patient in a sickle cell crisis reporting 9/10 pain, believe the patient and medicate — the correct answer is essentially never "reassess in an hour" or "assess for drug-seeking behavior."
🚩 Acute chest syndrome — fever, chest pain, cough, hypoxia, new pulmonary infiltrate. The leading cause of death in sickle cell disease. Medical emergency: oxygen, antibiotics, analgesia, transfusion, incentive spirometry. Other crises: splenic sequestration (rapid splenomegaly + shock), aplastic (parvovirus B19), hyperhemolytic. Chronic management: hydroxyurea (increases fetal hemoglobin), folic acid, penicillin prophylaxis and vaccination in childhood, transcranial Doppler for stroke risk, chronic transfusion with chelation, newer agents (crizanlizumab, voxelotor) and gene therapies.
Protocol: large-bore IV (18–20 gauge); 0.9% normal saline ONLY (dextrose hemolyzes, LR's calcium clots); two-nurse verification of patient identifiers, blood type, unit number, and expiration; baseline vitals; stay with the patient for the first 15 minutes (severe reactions occur early); vitals at 15 minutes and per protocol; complete infusion within 4 hours.
🚩 Any suspected reaction — first action: STOP the transfusion. Keep the line open with normal saline using new tubing. Notify the provider and blood bank. Stay with the patient. Send the unit and tubing back.
| Reaction | Signs |
|---|---|
| Acute hemolytic (ABO incompatibility — worst) | Fever, chills, flank/back pain, hypotension, hemoglobinuria, sense of doom, DIC |
| Febrile non-hemolytic (most common) | Fever, chills, headache — leukocyte-reduced products reduce risk |
| Allergic / anaphylactic | Urticaria and itching → bronchospasm, hypotension |
| TACO (circulatory overload) | Dyspnea, crackles, JVD, hypertension — slow rate, diuretics, sit up |
| TRALI (acute lung injury) | Acute respiratory distress, hypoxemia, hypotension, bilateral infiltrates within 6 h |
TACO versus TRALI: overload runs the BP up; lung injury runs it down.
Platelets 150,000–450,000. <50k bleeding with trauma · <20k spontaneous bleeding · <10k critical, spontaneous intracranial hemorrhage risk. ITP: autoimmune platelet destruction → corticosteroids → IVIG → thrombopoietin receptor agonists → splenectomy. 🚩 HIT (heparin-induced thrombocytopenia): platelet drop >50% typically 5–10 days after heparin exposure — paradoxically causes thrombosis, not bleeding. Action: stop ALL heparin, including flushes and heparin-coated catheters. Start a non-heparin anticoagulant (argatroban). Never give platelets.
+ NEW DIC: widespread microvascular clotting consumes platelets and clotting factors → simultaneous clotting and bleeding. Triggers: sepsis, obstetric emergencies, trauma, burns, malignancy. Labs: ↓platelets, ↓fibrinogen, ↑PT/aPTT, ↑↑D-dimer, schistocytes. Treat the underlying cause; support with FFP, cryoprecipitate, platelets.
+ NEW Neutropenia: ANC <500 = severe. Fever in a neutropenic patient is an emergency — cultures then antibiotics within one hour; do not wait for the source. Protective precautions: meticulous hand hygiene, no fresh flowers/standing water, well-cooked food, no rectal temperatures/suppositories/enemas, avoid crowds and sick contacts, no live vaccines, monitor for subtle signs (fever may be the only sign — the usual inflammatory findings require neutrophils to produce them).
PAD: atherosclerotic reduction of arterial flow. Risk: smoking (the strongest modifiable factor), diabetes, HTN, hyperlipidemia, age. Findings: intermittent claudication (reproducible pain with exercise, relieved by rest), rest pain relieved by dangling the leg, diminished/absent pulses, cool, pale, shiny, hairless skin, thick nails, delayed capillary refill. ABI <0.90.
| Arterial (PAD) | Venous insufficiency | |
|---|---|---|
| Pulses | Diminished or absent | Present |
| Skin | Cool, pale, shiny, hairless | Warm, brown hemosiderin staining, edema |
| Ulcers | Toes, lateral malleolus, pressure points — painful, punched-out, dry | Medial malleolus — weepy, shallow, irregular, less painful |
| Position | DANGLE (dependent) | ELEVATE |
| Compression | Contraindicated if severe | Therapeutic |
Hook: Arterial = dangle. Venous = elevate. Getting these backwards is one of the most common errors on this content. Management: smoking cessation, supervised exercise/walking program (walk to pain, rest, repeat), meticulous foot care, antiplatelet (aspirin/clopidogrel), cilostazol, statin, revascularization. 🚩 Acute arterial occlusion — the 6 P's: Pain, Pallor, Pulselessness, Paresthesia, Paralysis, Poikilothermia. Limb-threatening emergency; notify immediately, keep the limb dependent and at room temperature, do not elevate or apply heat/cold.
| Type | Mechanism | Distinguishing finding |
|---|---|---|
| Hypovolemic | Volume loss (hemorrhage, GI losses, burns) | Flat neck veins, ↓CVP, cool clammy skin |
| Cardiogenic | Pump failure (MI) | JVD and pulmonary edema together |
| Septic (distributive) | Vasodilation + capillary leak | Early: warm, flushed, bounding, ↑lactate. Late: cold and mottled |
| Anaphylactic (distributive) | Massive histamine release | Urticaria, angioedema, stridor/wheeze → epinephrine IM immediately |
| Neurogenic (distributive) | Loss of sympathetic tone (spinal injury above T6) | The only shock with BRADYCARDIA + hypotension + warm, dry skin |
| Obstructive | Mechanical (PE, tamponade, tension pneumothorax) | JVD with clear or unilateral lung findings |
Compensatory stage is where you catch it: tachycardia, tachypnea, narrowing pulse pressure, restlessness/anxiety (the earliest sign of cerebral hypoperfusion), cool clammy skin, decreasing urine output (<0.5 mL/kg/h). Blood pressure falls late. Sepsis bundle: measure lactate, obtain blood cultures before antibiotics, broad-spectrum antibiotics within 1 hour, 30 mL/kg crystalloid for hypotension or lactate ≥4, vasopressors (norepinephrine first-line) for persistent hypotension.
Through-line: make · store · expel. The kidney makes urine (AKI, CKD, glomerular disease), the bladder stores it (incontinence, retention), and the outflow tract expels it (BPH, stones, strictures). Every U8 topic breaks at one of those three points. Anchors: your 68-year-old BPH→TURP patient, the recurrent-UTI woman, the renal-colic patient.
| Problem | Break point | Key |
|---|---|---|
| BPH | Expel (obstruction) | TURP → continuous bladder irrigation; TURP syndrome = dilutional hyponatremia |
| Erectile dysfunction | Function | PDE-5 inhibitor + nitrate = fatal hypotension ↩7.3 |
| Incontinence | Store (leak) | Five types; behavioral first, then pharmacology |
| UTI | Infection | Upper tract = CVA tenderness + fever; → urosepsis |
| Calculi | Expel (obstruction) | Renal colic = writhing patient; strain all urine |
Non-malignant prostatic enlargement compressing the urethra. LUTS: hesitancy, weak stream, straining, intermittency, incomplete emptying, frequency, urgency, nocturia. Complications: retention, UTI, hydronephrosis, renal insufficiency.
| Class | Drugs | Pearl |
|---|---|---|
| Alpha-1 blockers (-osin) | Tamsulosin, doxazosin, terazosin | Rapid symptom relief (days). First-dose orthostatic syncope — give at bedtime. Also lowers BP ↩7.1. Retrograde ejaculation. Floppy iris syndrome — tell the ophthalmologist before cataract surgery →U10 |
| 5-alpha-reductase inhibitors | Finasteride, dutasteride | Shrinks the gland — 3–6 months for effect. Lowers PSA by ~50% — double the value when screening. Teratogenic: pregnant or potentially pregnant people must not handle crushed/broken tablets |
| Combination / PDE-5 | Tadalafil | Treats BPH and ED; nitrate contraindication stands |
TURP nursing — a reliable HESI target: - Continuous bladder irrigation (CBI) with isotonic solution. Output = total drainage minus irrigant instilled — chart true urine output separately. - Priority: keep the catheter draining. Obstruction is the emergency. Clots, bladder spasm, decreased output, suprapubic distension, and increasing pain mean occlusion → increase the irrigation rate; hand-irrigate per order. - Expected: light pink to pink-tinged return that clears over the first 24 hours. - 🚩 Bright red drainage with clots = arterial bleeding → increase irrigation and notify the surgeon. - Traction on the catheter (taped to the thigh) provides tamponade — do not release it without an order. - Bladder spasms are common — antispasmodics (belladonna and opium suppositories, oxybutynin); do not simply increase irrigation for spasm alone. - 🚩 TURP SYNDROME: absorption of hypotonic irrigation fluid → dilutional hyponatremia. Confusion, restlessness, headache, nausea, bradycardia, hypertension, visual changes, seizures. ↩ This is Exam 1's "Na⁺ <120 = cerebral edema" rule in a surgical wrapper. Stop the irrigation, notify immediately, anticipate hypertonic saline. - Teaching: avoid straining/heavy lifting/constipation for 4–6 weeks; expect intermittent hematuria for weeks; increase fluids; retrograde ejaculation is common and not harmful.
Vascular, neurologic, endocrine, medication-related (beta-blockers, thiazides, SSRIs, antipsychotics), or psychogenic. Frequently the first sign of cardiovascular disease — it warrants a cardiac workup, not just a prescription. PDE-5 inhibitors (sildenafil, tadalafil, vardenafil): 🚩 absolutely contraindicated with any nitrate — the combination causes profound, refractory hypotension. Caution with alpha-blockers (additive hypotension), severe cardiac disease. Report priapism >4 hours (emergency) and sudden vision or hearing loss.
| Type | Mechanism | Management |
|---|---|---|
| Stress | ↑abdominal pressure (cough, laugh, lift) overcomes a weak sphincter | Pelvic floor muscle training (Kegels) is first-line, weight loss, pessary, sling |
| Urge (overactive bladder) | Detrusor overactivity | Bladder training/timed voiding, antimuscarinics (oxybutynin, tolterodine — anticholinergic burden, confusion in older adults) or mirabegron (beta-3 agonist — safer cognitively, monitor BP) |
| Overflow | Retention from obstruction or an underactive detrusor | Relieve obstruction; bladder scan; intermittent catheterization; treat BPH |
| Functional | Physical/cognitive barriers, not urinary tract disease | Environment, scheduled toileting, accessible clothing, bedside commode |
| Mixed | Stress + urge | Combined approach |
Non-pharmacologic first, always. In older adults, prefer mirabegron over anticholinergics — antimuscarinics add to anticholinergic burden and can precipitate delirium →U9.
Lower (cystitis): dysuria, frequency, urgency, suprapubic pain, cloudy/malodorous urine, hematuria. Upper (pyelonephritis): the lower symptoms plus fever, chills, flank pain, and CVA tenderness, nausea/vomiting. → risk of urosepsis. 🚩 In an older adult, new confusion may be the only presentation. New-onset delirium in an elder = look for UTI, hypoxia, dehydration, medications ↩U4 · →U9. But: asymptomatic bacteriuria is common in older adults and is not treated — a positive culture without symptoms is not an infection.
Antibiotics: nitrofurantoin, TMP-SMX, fosfomycin for uncomplicated cystitis. 🚩 Nitrofurantoin and fosfomycin do NOT achieve adequate renal parenchymal concentrations — never for pyelonephritis (fluoroquinolone, ceftriaxone, or aminoglycoside instead). ↩U4 Sulfonamides: Stevens-Johnson, photosensitivity, hyperkalemia, crystalluria — push fluids. Fluoroquinolones: tendon rupture, QT prolongation, CNS effects. Prevention teaching: adequate fluids, void every 2–3 hours and after intercourse, front-to-back wiping, cotton underwear, avoid spermicides/diaphragms if recurrent, cranberry has weak evidence. CAUTI prevention: insert only when indicated, sterile technique, keep the bag below bladder level and off the floor, maintain a closed system, secure the tubing, remove as early as possible — duration is the dominant risk factor.
Types: calcium oxalate (most common), calcium phosphate, uric acid, struvite (infection-associated, staghorn), cystine. 🚩 Renal colic: excruciating flank pain radiating to the groin/labia/testicle, the patient cannot find a comfortable position and writhes — the diagnostic contrast with peritonitis, where the patient lies perfectly still ↩6.5. Hematuria, nausea/vomiting, diaphoresis. Diagnosis: non-contrast CT. Management: pain control first (NSAIDs ± opioids), hydration, strain all urine and send the stone for analysis, alpha-blocker (tamsulosin) as medical expulsive therapy for distal stones, lithotripsy or ureteroscopy for larger stones. 🚩 Obstructing stone + fever = urologic emergency — infection behind an obstruction becomes urosepsis rapidly; requires urgent decompression (stent or nephrostomy), not just antibiotics. Prevention by type: ≥2.5–3 L fluid daily for everyone; calcium oxalate → limit oxalate (spinach, rhubarb, nuts, tea, chocolate) but do not restrict dietary calcium; uric acid → limit purines, alkalinize urine, allopurinol; struvite → treat infection.
Abrupt decline in kidney function with retention of nitrogenous waste. KDIGO criteria: creatinine rise ≥0.3 mg/dL within 48 h, or ≥1.5× baseline within 7 days, or urine output <0.5 mL/kg/h for ≥6 h.
| Category | Mechanism | Causes | Urine/lab signature |
|---|---|---|---|
| Prerenal (~60%) | ↓perfusion; kidney is structurally intact | Hypovolemia, hemorrhage, HF, sepsis, cirrhosis, NSAIDs, ACEi/ARB, renal artery stenosis | BUN:Cr >20:1, urine Na⁺ <20, FENa <1%, concentrated urine, high specific gravity |
| Intrarenal / intrinsic | Structural damage — usually acute tubular necrosis | Prolonged ischemia; nephrotoxins: aminoglycosides, vancomycin, amphotericin, NSAIDs, contrast; rhabdomyolysis (myoglobin), hemolysis; glomerulonephritis; acute interstitial nephritis | BUN:Cr ~10–15:1, urine Na⁺ >40, FENa >2%, muddy brown granular casts, isosthenuric urine (SG ~1.010) |
| Postrenal | Obstruction | BPH, stones, tumor, blocked catheter, neurogenic bladder | Bladder scan; obstruction relief reverses it |
Prerenal is reversible if you restore perfusion; sustained prerenal injury becomes ATN. That progression is the reason fluid status is the priority assessment.
The four phases — HESI tests which complication belongs to which:
| Phase | Duration | Danger |
|---|---|---|
| Onset/initiation | Hours–days | The insult; often subtle |
| Oliguric | 8–14 days (up to weeks) | <400 mL/day. HYPERKALEMIA (the killer), metabolic acidosis, fluid overload/pulmonary edema, hypertension, ↑BUN/Cr, hyperphosphatemia, hypocalcemia, hyponatremia |
| Diuretic | 1–3 weeks | Up to 3–5 L/day. Now the risk flips: HYPOkalemia, hyponatremia, hypovolemia, dehydration. Nitrogenous wastes begin to fall late in this phase |
| Recovery | Up to 12 months | Gradual return of function; some do not fully recover |
🚩 Hyperkalemia is the leading cause of death in AKI. ECG: peaked T waves → widened QRS → loss of P waves → sine wave → arrest. Treatment sequence — memorize the order: 1. IV calcium gluconate — stabilizes the myocardium. Does not lower potassium. Buys time. 2. Shift it in: regular insulin with dextrose (±albuterol nebulized; sodium bicarbonate if acidotic). 3. Remove it: loop diuretic if urine output preserved; potassium binder (sodium zirconium cyclosilicate, patiromer, sodium polystyrene sulfonate); dialysis is definitive.
Nursing priorities in AKI: strict I&O and daily weights (the most sensitive fluid indicator), fluid restriction in the oliguric phase, potassium restriction and holding potassium-sparing agents/ACEi/ARB/NSAIDs, adjust all renally cleared drug doses, monitor for infection (the leading cause of death overall in AKI), nutrition support. Contrast-associated AKI prevention: isotonic IV hydration before and after, use the minimum contrast volume, hold metformin at the time of the study and for 48 hours after (lactic acidosis risk), avoid stacking nephrotoxins.
Progressive, irreversible loss of nephrons ≥3 months. Causes: diabetes (#1) and hypertension (#2).
Staging by eGFR: G1 ≥90 · G2 60–89 · G3a 45–59 · G3b 30–44 · G4 15–29 · G5 <15 (ESRD, requires replacement therapy). Staged jointly with albuminuria: A1 <30, A2 30–300, A3 >300 mg/g — albuminuria predicts progression independently of GFR.
Uremic manifestations, by system: - Neuro: fatigue, difficulty concentrating, asterixis, peripheral neuropathy, restless legs, encephalopathy, seizures - Cardiac: hypertension, HF, uremic pericarditis (friction rub — a dialysis indication), accelerated atherosclerosis (the #1 cause of death in CKD) - Heme: anemia (↓erythropoietin), platelet dysfunction → bleeding despite a normal count - GI: anorexia, nausea, metallic taste, uremic fetor, GI bleeding - Skin: pruritus (phosphate deposition), sallow/gray color, uremic frost (late) - Metabolic: metabolic acidosis ↩ (the kidney can neither excrete acid nor regenerate bicarbonate — this is why CKD lives in the same acid-base framework you already know), hyperkalemia, hyperphosphatemia, hypocalcemia
🚩 CKD–mineral and bone disorder: the failing kidney can't activate vitamin D or excrete phosphate → ↑phosphate, ↓calcium → secondary hyperparathyroidism → the parathyroid pulls calcium out of bone → renal osteodystrophy (fractures) plus vascular calcification. Management: phosphate binders given WITH meals (calcium acetate, sevelamer, lanthanum — the timing is the point: they bind phosphate in food, not in blood), active vitamin D (calcitriol), calcimimetics, dietary phosphate restriction (dairy, cola, processed foods, nuts).
Pharmacologic management (KDIGO 2024): SGLT2 inhibitors are now recommended broadly in CKD — for type 2 diabetes with CKD at eGFR ≥20, and for CKD with eGFR ≥20 plus urine ACR ≥200 mg/g or with heart failure regardless of albuminuria; RAS inhibitors (ACEi or ARB) for CKD with moderate-to-severe albuminuria, continued even when eGFR falls below 30, and never combined ACEi + ARB + direct renin inhibitor; and a nonsteroidal MRA (finerenone) for type 2 diabetes with CKD, eGFR >25, normal potassium, and persistent albuminuria on maximally tolerated RAS inhibition — monitor potassium closely. Statins for cardiovascular risk. Nephrotoxin stewardship and sick-day medication rules (hold RAS inhibitors, SGLT2 inhibitors, diuretics, NSAIDs, and metformin during acute dehydrating illness) are emphasized as core patient education.
Diet: sodium restriction; potassium restriction (avoid bananas, oranges, potatoes, tomatoes, avocado, salt substitutes — salt substitutes are potassium chloride and are a classic HESI trap); phosphate restriction; moderate protein restriction pre-dialysis but increased protein once on hemodialysis (dialysis removes amino acids); fluid allowance ≈ 500–600 mL plus the previous day's urine output. Anemia: ESAs to a target hemoglobin of 10–11 g/dL — not normal (higher targets increase stroke and thrombotic events) plus iron repletion.
Hemodialysis — typically 3–4 hours, three times weekly.
| Access | Maturation | Notes |
|---|---|---|
| AV fistula (artery-to-vein anastomosis) | 6 weeks–4 months | Preferred — lowest infection and thrombosis risk, longest survival |
| AV graft (synthetic) | 2–4 weeks | Faster, higher infection/clotting risk |
| Central venous catheter | Immediate | Highest infection risk; bridge only |
🚩 Access nursing — near-guaranteed test content: - Assess patency every shift: PALPATE for a thrill, AUSCULTATE for a bruit. Absent thrill/bruit = clotted = notify immediately. - NO blood pressures, venipunctures, IV starts, injections, or constrictive clothing/jewelry in the access extremity. Post a sign. - Assess distal circulation — cool, pale, numb, or painful hand suggests steal syndrome. - Hold pressure without occluding after needle removal; monitor for bleeding.
Around a dialysis run: weigh before and after (the difference is fluid removed); hold antihypertensives and dialyzable medications until after treatment (check the list — many antibiotics, digoxin, and water-soluble vitamins are removed); assess for hypotension, cramping, nausea. 🚩 Dialysis disequilibrium syndrome: rapid urea clearance from blood creates an osmotic gradient pulling water into the brain → headache, nausea, restlessness, confusion, seizures, usually during or just after early treatments. Slow or stop the rate and notify.
Peritoneal dialysis — dialysate instilled via a peritoneal catheter, dwells, then drains by gravity. - 🚩 Peritonitis is the #1 complication. CLOUDY EFFLUENT is the cardinal sign — report immediately (also abdominal pain, fever, rebound). Meticulous aseptic technique at every exchange. - Outflow less than inflow: reposition the patient, check for kinks, ensure the bag is below the abdomen, treat constipation (a full colon is the most common cause). - Warm the dialysate (never in a microwave) — cold fluid causes cramping. - Expect protein loss in the effluent → higher protein diet; monitor glucose (dextrose absorption). - Advantages: home-based, continuous, more dietary latitude, no anticoagulation.
+ NEW Kidney transplant: immunosuppression is lifelong (calcineurin inhibitors, mycophenolate, steroids) → infection and malignancy risk; teach sun protection, avoid live vaccines and crowds, meticulous hygiene. 🚩 Rejection signs: fever, tenderness over the graft, decreased urine output, rising creatinine, weight gain, hypertension, malaise. Report immediately. Never miss immunosuppressant doses.
Through-line: neurons die · a transmitter goes missing · pain misfires. Alzheimer's is loss of neurons; Parkinson's is loss of dopamine; myasthenia is loss of receptor signal; migraine and neuropathy are misfiring signal. Anchors: your 76-year-old with Alzheimer's and acute-on-chronic confusion, the 68-year-old with Parkinson's, the migraine patient.
Level of consciousness is the earliest and most sensitive indicator of neurologic change — before pupils, before vital signs. Any change in LOC gets reported. Glasgow Coma Scale (3–15): eye opening (4), verbal (5), motor (6). ≤8 = consider intubation. A drop of 2 points is significant. Pupils: size, equality, reactivity. A new unilateral fixed dilated pupil suggests uncal herniation — emergency. Pinpoint pupils suggest opioids or pontine lesion. 🚩 Cushing's triad (late sign of increased ICP): rising systolic pressure with WIDENING pulse pressure, BRADYCARDIA, and irregular respirations. By the time you see it, herniation is near. ↩U2 Never give hypotonic fluids to a patient with increased ICP or head injury — they worsen cerebral edema. Hypertonic saline (3%) and mannitol are the osmotic therapies; keep the head midline, HOB 30°, avoid hip flexion and Valsalva, cluster care to limit stimulation.
| Delirium | Dementia | |
|---|---|---|
| Onset | Acute (hours–days) | Gradual (months–years) |
| Course | Fluctuating, often worse at night | Steadily progressive |
| Attention | Markedly impaired | Preserved until late |
| Consciousness | Altered | Clear until late |
| Reversibility | YES — find and fix the cause | No |
🚩 New confusion in a hospitalized older adult is delirium until proven otherwise. Hunt the reversible cause: infection (especially UTI ↩U8), hypoxia, electrolytes (Na⁺, Ca²⁺, glucose), medications (anticholinergics, benzodiazepines, opioids), pain, dehydration, constipation/retention, sleep deprivation, alcohol withdrawal. Management: treat the cause, reorient, family presence, familiar objects, glasses and hearing aids on, mobilize, normalize the sleep-wake cycle, adequate light, avoid restraints. Antipsychotics only for danger, at the lowest dose, briefly. 🚩 Antipsychotics in older adults with dementia carry a boxed warning for increased mortality.
Progressive: short-term memory loss → language and executive deficits → agnosia/apraxia → total dependence. Drugs: cholinesterase inhibitors (donepezil, rivastigmine, galantamine — bradycardia, GI upset, vivid dreams; modest symptomatic benefit) and memantine (NMDA antagonist, moderate-to-severe disease). Newer anti-amyloid monoclonal antibodies (lecanemab, donanemab) require MRI monitoring for amyloid-related imaging abnormalities. Nursing: consistent routine and caregiver, simple one-step directions, break tasks down, redirect rather than argue or reality-orient into distress, safety first — wandering (door alarms, ID bracelet), driving, stove, medications, falls, evening "sundowning" (increase light, reduce stimulation), swallowing and aspiration risk later ↩U4, skin/continence care, caregiver strain is a nursing diagnosis — respite, support groups, advance directives early. Other dementias worth distinguishing: vascular (stepwise decline, focal findings); Lewy body (visual hallucinations, parkinsonism, fluctuating cognition — severe sensitivity to antipsychotics); frontotemporal (personality/behavior change first, younger onset).
Degeneration of dopaminergic neurons in the substantia nigra → dopamine deficit relative to acetylcholine. Cardinal signs — TRAP: Tremor (resting, pill-rolling, decreases with movement), Rigidity (cogwheel), Akinesia/bradykinesia, Postural instability. Plus masked facies, shuffling festinating gait, micrographia, hypophonia, drooling, freezing, constipation, orthostatic hypotension, depression, late dementia.
| Drug | Pearl |
|---|---|
| Carbidopa–levodopa | Gold standard. Timing is sacred — give exactly on schedule; a late dose means an "off" period of immobility. Separate from high-protein meals (dietary amino acids compete for the same transporter). Orthostatic hypotension, nausea, dyskinesias and wearing-off with long-term use, darkened sweat/urine (harmless) |
| Dopamine agonists (pramipexole, ropinirole) | 🚩 Impulse-control disorders — pathologic gambling, hypersexuality, compulsive shopping and eating. Counsel the patient AND the family, because the patient often does not report it. Also somnolence/sleep attacks, hallucinations |
| MAO-B inhibitors (selegiline, rasagiline) | Adjunct; avoid tyramine-rich foods at higher doses; serotonin syndrome risk with SSRIs/meperidine |
| COMT inhibitors (entacapone) | Extends levodopa; brown-orange urine |
| Anticholinergics (benztropine, trihexyphenidyl) | Tremor-predominant, younger patients; avoid in older adults — confusion, retention, constipation |
| Amantadine | Dyskinesia; livedo reticularis |
Nursing: fall prevention, swallowing evaluation and aspiration precautions, thickened liquids if needed, high-fiber diet and fluids for constipation, physical/occupational/speech therapy, allow extra time, warm baths and massage for rigidity, monitor for depression. Never abruptly stop levodopa — risk of a neuroleptic-malignant-like syndrome.
Autoimmune demyelination of the CNS; most commonly relapsing–remitting. Women, ages 20–40, higher latitudes. Findings: optic neuritis (painful monocular vision loss), diplopia/internuclear ophthalmoplegia, overwhelming fatigue, weakness, spasticity, ataxia, paresthesias, Lhermitte's sign (electric sensation down the spine with neck flexion), bladder dysfunction, cognitive changes, intention tremor. 🚩 Uhthoff's phenomenon: heat transiently worsens symptoms — avoid hot baths, hot tubs, saunas, overheating; cooling strategies are a nursing intervention, not a comfort measure. Acute relapse: high-dose IV methylprednisolone. Disease-modifying therapies: interferon beta (flu-like symptoms — dose at bedtime, premedicate), glatiramer, natalizumab (progressive multifocal leukoencephalopathy risk — JC virus testing), fingolimod (first-dose bradycardia — six-hour cardiac monitoring), ocrelizumab, dimethyl fumarate (flushing), teriflunomide (teratogenic). Symptom management: baclofen/tizanidine (spasticity), amantadine/modafinil (fatigue), oxybutynin or intermittent catheterization (bladder), gabapentin (neuropathic pain). Teaching: energy conservation and planned rest, avoid infection and extreme heat, exercise within tolerance, safety/fall prevention, the disease course is unpredictable — this is a chronic-illness-adjustment nursing problem as much as a neurologic one.
Autoantibodies against postsynaptic acetylcholine receptors at the neuromuscular junction. Often thymic pathology. Hallmark: DESCENDING weakness that worsens with activity and improves with rest — worst at the end of the day. Ptosis and diplopia are typically first; then dysphagia, dysarthria, chewing fatigue, proximal limb weakness, and respiratory muscle weakness. Diagnosis: acetylcholine receptor antibodies, edrophonium (Tensilon) test, EMG, chest imaging for thymoma. Treatment: pyridostigmine (anticholinesterase), immunosuppression, thymectomy, plasmapheresis/IVIG for crisis.
🚩 The classic HESI item — myasthenic versus cholinergic crisis. Both present with severe weakness and respiratory failure:
| Myasthenic crisis | Cholinergic crisis | |
|---|---|---|
| Cause | UNDER-medication, infection, stress, surgery, missed doses, certain drugs | OVER-medication with anticholinesterase |
| Extra findings | Tachycardia, ↑BP, restlessness, absent cholinergic signs | SLUDGE — Salivation, Lacrimation, Urination, Defecation, GI cramping, Emesis — plus miosis, fasciculations, bradycardia, sweating |
| Edrophonium test | Improves | Worsens |
| Treatment | More anticholinesterase; supportive ventilation | Hold anticholinesterase; atropine; supportive ventilation |
Both are airway emergencies. ↩ Monitor vital capacity and negative inspiratory force — not pulse oximetry. SpO₂ stays normal until the patient is nearly apneic, because the problem is ventilatory muscle failure, not gas exchange. Falling vital capacity is the early warning. Pyridostigmine timing: give 30–60 minutes BEFORE meals so the patient has strength to chew and swallow. 🚩 Drugs to avoid in myasthenia: aminoglycosides, magnesium, beta-blockers, certain antiarrhythmics, neuromuscular blockers.
Autoimmune demyelination of peripheral nerves, typically 1–3 weeks after a respiratory or GI infection (Campylobacter jejuni classically). Hallmark: ASCENDING, symmetric, flaccid paralysis with areflexia, beginning in the legs. Paresthesias precede weakness. Ascending is the discriminator against myasthenia's descending pattern. 🚩 Priority is respiratory: serial vital capacity and negative inspiratory force; VC <15–20 mL/kg or a rapidly falling trend → prepare for intubation. Do not wait for hypoxia. Autonomic instability: labile blood pressure, dysrhythmias, ileus, urinary retention — continuous monitoring. Treatment: plasmapheresis or IVIG. Corticosteroids are NOT effective. Nursing: DVT and pressure injury prevention, nutrition, pain (often significant neuropathic pain), communication method while ventilated, reassurance — the patient is fully alert inside a paralyzed body, intensive rehabilitation. Most recover substantially.
🚩 Headache red flags requiring urgent evaluation: - Thunderclap — sudden, maximal at onset, "worst headache of my life" → subarachnoid hemorrhage - Fever + nuchal rigidity + photophobia → meningitis (Kernig/Brudzinski; droplet precautions until cause known) - New headache with focal deficit, papilledema, seizure, or altered LOC - New headache after age 50, or in an immunocompromised or pregnant patient - Headache worsened by exertion, position, or Valsalva
Migraine: unilateral, throbbing, moderate-to-severe, with photophobia/phonophobia, nausea, ± aura; worsened by activity. Acute treatment: NSAIDs/acetaminophen early; triptans (sumatriptan) — 🚩 contraindicated in coronary artery disease, uncontrolled hypertension, and cerebrovascular disease (vasoconstriction); do not combine with ergots; ergotamines — same vascular contraindications plus absolute contraindication in pregnancy; antiemetics; gepants (ubrogepant, rimegepant) as a safer option in cardiovascular disease; ditans (lasmiditan — no driving for 8 hours). 🚩 Medication-overuse headache: treating more than ~10–15 days per month perpetuates the cycle. Prevention: CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab) and gepants are now positioned as first-line preventives rather than last-resort; also topiramate (paresthesias, weight loss, kidney stones, teratogenic), beta-blockers, TCAs, valproate (teratogenic), botulinum toxin for chronic migraine. Nursing: identify triggers with a headache diary (sleep, stress, hormones, alcohol, aged cheese, nitrates, skipped meals, weather), dark quiet room during an attack, cold compress, treat early rather than waiting.
"Pain is whatever the experiencing person says it is, existing whenever they say it does." Self-report is the gold standard; there is no objective test, and normal vital signs do not disprove pain (autonomic responses adapt in chronic and persistent pain).
Assessment tools: numeric rating scale; Wong–Baker FACES (children, language barriers); FLACC (nonverbal, infants); PAINAD (advanced dementia); CPOT/BPS (critically ill, intubated). OLDCARTS/PQRST for characterization.
🚩 The equity dimension — and it is testable. Black patients are systematically under-assessed and under-treated for pain across emergency, surgical, and oncology settings, a disparity that persists after controlling for insurance, income, and disease severity, and is driven in part by false beliefs about biological differences in pain sensitivity. On HESI, the correct action when a patient reports severe pain is to believe and treat, not to delay, reassess later, or evaluate for drug-seeking behavior. This is where clinical correctness and justice point the same direction.
Pharmacology:
| Tier | Agents | Nursing |
|---|---|---|
| Non-opioid | Acetaminophen (max 3–4 g/day; hepatotoxicity — check every combination product); NSAIDs (GI bleeding, renal injury — avoid in CKD ↩U8, cardiovascular risk, avoid with anticoagulants) | Foundation of multimodal analgesia; opioid-sparing |
| Opioid | Morphine (avoid in renal failure — active metabolites accumulate), hydromorphone, oxycodone, fentanyl (transdermal is for opioid-tolerant chronic pain only — never opioid-naive; heat increases absorption) | 🚩 Meperidine should be avoided — normeperidine accumulates and causes seizures |
| Adjuvant | Gabapentin, pregabalin, duloxetine, TCAs (neuropathic); corticosteroids; lidocaine patch; ketamine | Neuropathic pain responds poorly to opioids alone |
🚩 Opioid safety: sedation precedes respiratory depression — a sedation scale is the early warning, not respiratory rate. Constipation is the one adverse effect that never develops tolerance → prophylactic stimulant laxative from day one ↩U5. Also nausea, pruritus, urinary retention, hypotension. Naloxone reverses but has a shorter half-life than most opioids — monitor for re-sedation and be prepared to re-dose; it precipitates withdrawal and returns the pain. 🚩 PCA: only the patient presses the button. No PCA by proxy — no family, no staff. The built-in safety is that a sedated patient cannot self-administer. Teach the patient to dose before activity; monitor sedation and respiratory rate. Non-pharmacologic: repositioning, heat/cold, massage, distraction, relaxation, guided imagery, music, TENS, acupuncture — adjuncts, not substitutes.
Through-line: the electrical storm (seizures) and the failing sensors (eye, ear). Both are safety units — almost every correct answer is a safety action. Anchors: your pregnancy-planning woman with epilepsy; the seizure that will not stop.
| Type | Features |
|---|---|
| Focal aware (simple partial) | Consciousness preserved; motor, sensory, or autonomic symptoms |
| Focal impaired awareness (complex partial) | Altered awareness, automatisms (lip-smacking, picking), postictal confusion |
| Focal to bilateral tonic–clonic | Begins focally, generalizes |
| Generalized tonic–clonic | Loss of consciousness, tonic rigidity → clonic jerking, incontinence, tongue biting, postictal confusion and drowsiness |
| Absence | Brief staring/blanking, no postictal phase — often mistaken for inattention in school |
| Myoclonic | Brief shock-like jerks |
| Atonic ("drop attack") | Sudden loss of tone; high injury risk — helmet |
Phases: prodrome → aura (itself a focal seizure and a warning to get to safety) → ictal → postictal. Precipitants: missed medication doses (the most common), sleep deprivation, alcohol/withdrawal, infection/fever, flashing lights, stress, hypoglycemia, electrolyte derangement (↩ hyponatremia, hypocalcemia, hypomagnesemia).
During: - Stay with the patient. Time the seizure. - Turn side-lying (protects the airway), protect the head, loosen restrictive clothing, clear the area of hazards. - DO NOT restrain. DO NOT put anything in the mouth. Both cause injury; the tongue cannot be swallowed. - Suction and oxygen available; do not force a suction catheter or airway during the tonic phase. - Observe and document: onset, aura, motor pattern and progression, eye deviation, duration, incontinence, cyanosis, postictal state.
After: maintain side-lying, assess airway and vitals, suction as needed, reorient calmly and repeatedly, allow rest, assess for injury, privacy and dignity — witnessed seizures are humiliating. Hospital seizure precautions: bed in the low position, side rails padded and up, suction and oxygen at the bedside, IV access for high-risk patients, no oral temperatures, supervised ambulation and showering.
Definition: a seizure lasting ≥5 minutes, or repeated seizures without return to baseline between them. Mortality rises with duration; neuronal injury begins around 30 minutes.
Sequence — the order is the answer: 1. ABC — airway positioning, suction, oxygen, IV access, check glucose, cardiac and pulse-ox monitoring. 2. First-line: a benzodiazepine — IV lorazepam, or IM midazolam if no IV access, or rectal diazepam. 3. Second-line: an IV antiseizure medication — levetiracetam, fosphenytoin, or valproate. Comparative trial evidence found these three roughly equivalent, so any of them appearing as the correct option is defensible. 4. Refractory: anesthetic infusion (midazolam, propofol, pentobarbital) with intubation and continuous EEG. 5. Throughout: identify and treat the precipitant — hypoglycemia, hyponatremia, hypocalcemia, infection, drug withdrawal, missed doses, eclampsia.
🚩 Never stop antiseizure medications abruptly — abrupt withdrawal is a leading precipitant of status epilepticus.
| Drug | Level | Signature toxicity / teaching |
|---|---|---|
| Phenytoin | 10–20 mcg/mL | 🚩 IV compatibility: NORMAL SALINE ONLY — never dextrose (precipitates). Max rate 50 mg/min (fosphenytoin 150 mg PE/min) with cardiac monitoring — faster causes hypotension and dysrhythmias. Gingival hyperplasia — meticulous oral care and dental follow-up. Hirsutism, nystagmus → ataxia → confusion as the level climbs, rash/Stevens–Johnson, purple glove syndrome, folate depletion, osteoporosis. Strong CYP inducer |
| Carbamazepine | 4–12 mcg/mL | 🚩 Hyponatremia/SIADH (↩ — another route to Na⁺ <120), agranulocytosis and aplastic anemia — monitor CBC, Stevens–Johnson associated with HLA-B*1502 (screen patients of Asian ancestry), diplopia, ataxia. CYP inducer. First-line for trigeminal neuralgia ↩9.8 |
| Valproate | 50–100 mcg/mL | 🚩 Highest teratogenic risk of any antiseizure medication — neural tube defects and reduced childhood IQ. Hepatotoxicity, pancreatitis, hyperammonemia, thrombocytopenia, weight gain, tremor, hair loss |
| Levetiracetam | Not routinely monitored | Behavioral and psychiatric effects — irritability, agitation, depression, suicidality. Renal dose adjustment. Minimal interactions; commonly preferred in pregnancy |
| Lamotrigine | Not routinely monitored | 🚩 Stevens–Johnson syndrome and toxic epidermal necrolysis — titrate slowly, much slower when combined with valproate. Any rash must be reported immediately. Otherwise favorable in pregnancy |
| Phenobarbital | 15–40 mcg/mL | Sedation, cognitive slowing, dependence, respiratory depression. Strong CYP inducer |
| Topiramate | Not routinely monitored | Word-finding difficulty, paresthesias, kidney stones (push fluids), weight loss, acute angle-closure glaucoma →10.6, teratogenic |
| Oxcarbazepine | — | Hyponatremia (like carbamazepine), better tolerated |
🚩 Enzyme-inducing antiseizure medications — phenytoin, carbamazepine, phenobarbital, and topiramate at higher doses — accelerate hormone metabolism and REDUCE oral contraceptive efficacy. This is the single most important reproductive-health teaching point in the unit: patients need higher-dose or non-hormonal contraception, and unplanned pregnancy on valproate carries the highest fetal risk.
🚩 ACUTE ANGLE-CLOSURE GLAUCOMA — the ophthalmologic emergency. Sudden severe eye pain, headache, nausea and vomiting, blurred vision with halos around lights, a fixed mid-dilated pupil, and a hard red eye. Vision loss occurs within hours. Immediate: notify, do not delay. Treatment is topical miotics (pilocarpine), acetazolamide, hyperosmotics, and definitive laser peripheral iridotomy. 🚩 Avoid anticholinergics, mydriatics, and pupil-dilating drugs in anyone at risk — this is why "blurred vision and eye pain" in a patient on an anticholinergic, a topiramate, or a scopolamine patch is an urgent finding, not a side effect to document.
Primary open-angle glaucoma (far more common): painless, insidious loss of PERIPHERAL vision progressing to tunnel vision; central acuity preserved until late; elevated intraocular pressure (normal 10–21 mmHg); cupping of the optic disc. Damage is irreversible; treatment prevents further loss. Lifelong drops — never stop, even though the patient feels nothing. Adherence teaching is the intervention.
| Drop class | Examples | Teaching |
|---|---|---|
| Prostaglandin analogs | Latanoprost | First-line, once daily at night. Permanent iris darkening, eyelash growth, periorbital pigmentation |
| Beta-blockers | Timolol | 🚩 Systemic absorption causes bradycardia and bronchospasm — caution in asthma/COPD ↩U4 and heart block. Teach punctal occlusion (press the inner canthus for 1–2 minutes) to reduce systemic uptake |
| Alpha agonists | Brimonidine | Allergic conjunctivitis, dry mouth, fatigue |
| Carbonic anhydrase inhibitors | Dorzolamide, oral acetazolamide | Sulfa-related; oral form causes paresthesias, ↓K⁺, kidney stones |
Instillation technique (teachable and testable): wash hands, tilt head back, pull down the lower lid to form a pocket, do not touch the tip to the eye, apply gentle punctal occlusion, wait 5 minutes between different drops, instill drops before ointments.
Cataracts: painless progressive blurring, glare and halos around lights, faded colors, difficulty driving at night, second sight. Risks: age, UV exposure, smoking, diabetes, corticosteroids, trauma. Surgery is outpatient phacoemulsification with lens implant, one eye at a time. 🚩 Post-op teaching: no bending at the waist, no lifting over ~10 lb, no straining/Valsalva, treat constipation, no coughing or sneezing suppression, do not rub the eye, wear the eye shield at night and sunglasses in daylight, sleep on the unoperated side. Report immediately: sudden eye pain (hemorrhage or acute pressure rise), a sudden increase in floaters or flashes of light (retinal detachment), decreasing vision, purulent drainage.
Age-related macular degeneration: CENTRAL vision loss with preserved peripheral vision — the mirror image of glaucoma. Metamorphopsia (straight lines appear wavy) and a central scotoma. Dry (atrophic, ~90%) — drusen, gradual; AREDS2 supplementation slows progression in intermediate disease; smoking cessation is the strongest modifiable factor. Wet (neovascular) — abrupt distortion; intravitreal anti-VEGF injections. Teaching: an Amsler grid daily; any new distortion or dark central spot is reported the same day. Low-vision rehabilitation, magnification, high-contrast lighting.
🚩 Retinal detachment — emergency. Painless. Sudden floaters ("spiderwebs," "soot"), flashes of light (photopsia), and a curtain or shadow moving across the visual field. Risks: high myopia, cataract surgery, trauma, diabetic retinopathy. Action: notify immediately, keep the patient still, position as directed to let the detached area settle, avoid sudden head movement and Valsalva. Repair by pneumatic retinopexy, scleral buckle, or vitrectomy. If an intraocular gas bubble is placed: strict face-down or prescribed positioning, and NO AIR TRAVEL or high-altitude travel until the bubble resorbs — the gas expands and can blind the patient.
Diabetic retinopathy: microvascular damage; leading cause of new blindness in working-age adults. Annual dilated eye examination. Glycemic and blood pressure control are the primary interventions; laser photocoagulation and anti-VEGF for advanced disease.
Conductive (outer/middle ear — cerumen impaction, otitis media with effusion, otosclerosis, perforation) versus sensorineural (inner ear or CN VIII — presbycusis, noise exposure, ototoxicity, Meniere's, acoustic neuroma) versus mixed. Weber test: lateralizes to the affected ear in conductive loss, away in sensorineural. Rinne: normally air conduction > bone conduction; reversed in conductive loss.
🚩 Ototoxic drugs — and note how many are already on your exam: aminoglycosides (gentamicin, tobramycin ↩U4), loop diuretics (furosemide ↩U7), vancomycin, cisplatin, high-dose salicylates, some antimalarials. Tinnitus is often the first sign — report it before hearing loss develops. Risk multiplies when agents are combined, and both aminoglycosides and loop diuretics are also nephrotoxic — a patient in AKI on both is at compounded risk ↩U8.
🚩 Meniere's disease — endolymphatic hydrops. The triad plus one: episodic, severe vertigo (minutes to hours) + tinnitus + fluctuating sensorineural hearing loss + aural fullness. Attacks come with nausea, vomiting, nystagmus, and profound imbalance. Nursing priority is SAFETY: during an attack, bed rest in a quiet, dimly lit room, side rails up, no sudden head movements, assist with all ambulation, no driving or operating machinery, no climbing or working at heights. Antiemetics and vestibular suppressants (meclizine, dimenhydrinate, benzodiazepines short-term), antihistamines/anticholinergics, sometimes intratympanic steroids. Between attacks: low-sodium diet, diuretics, limit caffeine, alcohol, and nicotine, manage stress, keep a symptom diary.
Other vestibular causes: BPPV — brief positional vertigo, diagnosed with the Dix–Hallpike maneuver and treated with the Epley repositioning maneuver; vestibular neuritis/labyrinthitis — acute, often post-viral, sustained vertigo. Otitis externa ("swimmer's ear"): pain on movement of the tragus or auricle; topical drops; keep the ear dry. Otitis media: ear pain, fever, bulging erythematous tympanic membrane, conductive loss. Acoustic neuroma: unilateral sensorineural loss with tinnitus and imbalance — unilateral hearing loss always warrants investigation.
Communicating with a person who has hearing loss: face the person at eye level in good light, get their attention first, speak in a normal-to-slightly-slower rate at a lower pitch — do not shout (shouting distorts speech and raises pitch, which is exactly the range lost in presbycusis), reduce background noise, rephrase rather than repeat, confirm understanding, ensure hearing aids are in and working. Never remove a hearing aid before surgery without a plan — sensory deprivation is a major contributor to perioperative delirium ↩9.2.
This is what separates a 900 from an 1100 on a cumulative exam. HESI builds items at the joins between units — the same finding meaning different things, the drug that collides across two systems, the chain that starts in the liver and ends in the kidney. Drill this Saturday.
This is the part that separates a 900 from a 1100 on a cumulative exam. HESI builds items at the seams between units. Drill this section Saturday.
| Source | Disturbance | Why |
|---|---|---|
| Diarrhea, ileostomy output, lower-GI loss | Metabolic ACIDOSIS | Loses bicarbonate-rich fluid from below |
| Vomiting, NG suction, upper-GI loss | Metabolic ALKALOSIS | Loses hydrochloric acid from above |
| AKI / CKD | Metabolic ACIDOSIS | Kidney can neither excrete acid nor regenerate bicarbonate |
| Loop and thiazide diuretics | Metabolic alkalosis + hypokalemia | Contraction alkalosis |
| Salicylate overdose | Mixed respiratory alkalosis + metabolic acidosis | Direct respiratory stimulation plus acid load |
| Respiratory muscle failure — myasthenic/cholinergic crisis, Guillain–Barré, opioid oversedation | Respiratory ACIDOSIS | Hypoventilation retains CO₂ |
| Refeeding syndrome | Not acid–base — ↓phosphorus, ↓potassium, ↓magnesium | Insulin drives them intracellularly |
One-line synthesis: lose acid from above → alkalosis; lose base from below or fail to excrete acid → acidosis.
| Direction | Where it comes from | What kills |
|---|---|---|
| HYPOkalemia | Diarrhea (U5) · NG suction/vomiting (U6) · loop and thiazide diuretics (U7) · AKI diuretic phase (U8) · insulin/DKA treatment · amphotericin, corticosteroids | Dysrhythmias; potentiates digoxin toxicity (U7); flat T waves, U waves; ileus; muscle weakness |
| HYPERkalemia | AKI oliguric phase and CKD (U8) · ACEi/ARB/ARNI, MRA, potassium-sparing diuretics (U7/U8) · salt substitutes · crush injury/rhabdomyolysis/hemolysis · acidosis (shifts K⁺ out of cells) · blood transfusion (older units) | Peaked T waves → wide QRS → sine wave → arrest. Treatment order: calcium gluconate → insulin+dextrose → remove (binder/diuretic/dialysis) |
If a single lab value could be the answer to "which finding requires immediate intervention," it is potassium.
| Cause | Direction |
|---|---|
| TURP syndrome (U8) — hypotonic irrigant absorption | ↓Na⁺, acute — seizure risk |
| Carbamazepine / oxcarbazepine (U10) — SIADH | ↓Na⁺ |
| Cirrhosis with ascites, heart failure (U6/U7) | ↓Na⁺ (dilutional) |
| Diuretics, adrenal insufficiency | ↓Na⁺ |
| Dehydration, tube feeding without free water, diabetes insipidus | ↑Na⁺ |
🚩 Acute Na⁺ <120 → cerebral edema → seizures. Correct slowly (rapid correction causes osmotic demyelination). Seizure precautions and neuro checks are the nursing answer.
Each chain below is a plausible unfolding-case skeleton. Being able to see the whole chain from any one link is the skill being tested.
| Combination | Consequence |
|---|---|
| PDE-5 inhibitor + nitrate | Profound refractory hypotension (U8 + U7) |
| ACEi + ARNI | Angioedema — 36-hour washout (U7) |
| ACEi/ARB + MRA + potassium supplement or salt substitute | Hyperkalemia (U7 + U8) |
| Digoxin + loop or thiazide diuretic | Hypokalemia → digoxin toxicity (U7) |
| Aminoglycoside + loop diuretic | Compounded ototoxicity and nephrotoxicity (↩U4 + U7 + U8 + U10) |
| Enzyme-inducing antiseizure drug + oral contraceptive | Contraceptive failure (U10) |
| Valproate + lamotrigine | Markedly increased Stevens–Johnson risk; titrate much slower (U10) |
| Aminoglycoside, magnesium, or beta-blocker in myasthenia | Precipitates crisis (U9) |
| Anticholinergic in narrow angles | Acute angle-closure glaucoma (U10) |
| Anticholinergic in an older adult | Delirium, retention, constipation (U8 + U9) |
| NSAID in CKD or on anticoagulation | AKI; GI bleed (U8 + U6 + U7) |
| Triptan or ergot in coronary artery disease | Vasospasm/ischemia (U9 + U7) |
| Metformin + iodinated contrast | Lactic acidosis — hold 48 hours (U8) |
| Situation | Position |
|---|---|
| Arterial insufficiency / PAD | Dangle, dependent |
| Venous insufficiency / DVT | Elevate |
| Acute pulmonary edema, heart failure, dyspnea | High Fowler's, legs dependent |
| Peritonitis, post-abdominal surgery | Semi-Fowler's with knees flexed (localizes drainage, relieves tension) |
| Acute pancreatitis | Side-lying knees flexed, or upright leaning forward |
| Tube feeding, GERD, aspiration risk | HOB 30–45° |
| Seizure | Side-lying |
| Increased ICP | HOB 30°, head midline, avoid hip flexion |
| Post-cataract surgery | Sleep on the unoperated side, eye shield |
| Retinal detachment with a gas bubble | Prescribed positioning, often face-down |
| Meniere's attack | Flat or side-lying in a quiet dark room, minimal head movement |
| Peritoneal dialysis with poor outflow | Reposition the patient; drain bag below the abdomen |
| Autonomic dysreflexia / suspected shock with hypotension | Sit up for dysreflexia; flat with legs elevated for hypovolemic shock |
| Condition | Diet |
|---|---|
| CKD, pre-dialysis | ↓sodium, ↓potassium, ↓phosphorus, moderate protein restriction |
| CKD on hemodialysis | Same restrictions but increased protein |
| Fluid allowance in ESRD | ≈ 500–600 mL + previous day's urine output |
| Heart failure | ↓sodium (2–3 g); fluid restriction if hyponatremic |
| Cirrhosis with ascites | ↓sodium; protein NOT restricted |
| Diverticulosis (prevention) | High fiber |
| Diverticulitis (acute flare) | Low fiber / bowel rest |
| Celiac | Lifelong gluten-free |
| Post-bariatric | Small frequent meals, no fluids with meals, avoid simple sugars |
| Calcium oxalate stones | ↑fluids, ↓oxalate — do NOT restrict dietary calcium |
| Uric acid stones | ↓purine, alkalinize urine |
| Chronic pancreatitis | Low fat, enzymes with every meal, no alcohol |
| Parkinson's on levodopa | Separate levodopa from high-protein meals |
| Meniere's | Low sodium, limit caffeine/alcohol/nicotine |
| Warfarin | Consistent — not absent — vitamin K intake |
| MAO-B inhibitor at higher doses | Avoid tyramine |
| Iron supplementation | Empty stomach with vitamin C; avoid with dairy, antacids, tea |
| Task | RN | LPN | UAP |
|---|---|---|---|
| Initial stoma assessment after surgery | ✔ | ||
| Routine ostomy pouch emptying | ✔ | ✔ | |
| Blood transfusion verification and initiation | ✔ | ||
| Vital signs on a stable post-transfusion patient | ✔ | ✔ | |
| Assessing an AV fistula for thrill and bruit | ✔ | ||
| Reminding staff not to use the fistula arm for BP | ✔ | ✔ | ✔ (reinforce) |
| Neuro checks / GCS | ✔ | ||
| Feeding a patient with dysphagia | ✔ (assess first) | ✖ | |
| Feeding a patient without swallowing risk | ✔ | ✔ | |
| Initial teaching on a new antiseizure medication | ✔ | ||
| Reinforcing previously taught seizure precautions | ✔ | ||
| Titrating a heparin drip | ✔ | ||
| Instilling routine glaucoma drops (stable patient) | ✔ | ✔ | ✖ |
| Assisting a Meniere's patient to ambulate | ✔ | ✔ | |
| Interpreting a rising creatinine | ✔ |
The line: delegate the stable, routine, and predictable. Retain assessment, teaching, evaluation, and anything unstable or novel.
Generate the answer out loud before you flip. Retrieval builds durable memory; re-reading builds false confidence. Filter to a unit, shuffle, and repeat the misses.
Timed, no notes, no stopping — answer all thirty before you check anything. SATA items have no partial credit: judge each option independently instead of anchoring on how many you expect to be right.
—
If you read nothing else before you sit: these numbers and these red flags resolve a large fraction of HESI items on their own.
Sourcing, gap logic, guideline verification, and one stated limitation.
How this guide was constructed, and why it is shaped the way it is.
Source handling. Your two files were parsed rather than read — the HTML was tag-stripped in Python to separate rendered content from styling, then its embedded script block was read separately to recover the flashcard array and phase-plan objects, which is where the exam date and six-week schedule actually lived. Everything clinically sound in both files was preserved verbatim or near-verbatim; the tables you already know were not rewritten, because re-encoding familiar material in unfamiliar wording during a five-day window creates interference rather than depth.
Gap identification. Coverage was computed as a set difference: standard NCLEX-RN test-plan content for each of the six body systems, minus what your files demonstrably contained. Results were then ranked by expected point loss rather than topic count — which is why acute coronary syndrome and acute kidney injury were written at full length while irritable bowel syndrome received a paragraph, despite the latter category containing more discrete topics. A gap in a high-frequency, high-acuity domain costs more than several gaps in low-frequency ones.
Guideline verification was targeted, not exhaustive. Searches were run only where your files make a specific falsifiable claim that guidelines have plausibly moved past, and where I was authoring content fresh. That produced one substantive correction — the H. pylori regimen — and confirmed that your hypertension categories and heart-failure pillars are current. The H. pylori case is presented as both regimens deliberately: item banks lag guideline publication by years, so the exam-correct answer and the practice-correct answer can diverge, and the useful skill is knowing which is which rather than which is "right."
Why the + NEW tagging exists. Your files are a condensed working layer, not the full unit architectures, so I cannot distinguish "out of scope" from "not condensed." Tagging transfers that triage decision to you at negligible reading cost. Under-inclusion costs points on Sunday; over-inclusion costs a few minutes of scanning this week. The asymmetry favors including it.
Why the cross-system section exists at all. Exam 1 tested four units sharing one substrate. Six units that interact produce a qualitatively different item type — the cross-system stem — which is not learnable by studying units sequentially. Part 4 exists because the chains in §4.5 are the actual construction template for cumulative unfolding cases, and being able to traverse a chain from any link is a distinct skill from knowing each link.
Why the applied items include distractor logic. Reading a correct answer teaches recognition; articulating why a wrong answer is wrong teaches discrimination, which is what a four-option item actually measures. Several distractors were written to fail for specific diagnosable reasons — reversed arterial/venous positioning, anchoring on normal vital signs, treating a stabilizing agent as a lowering agent — so that a miss identifies a fixable reasoning pattern rather than a vague content gap.
Why the plan front-loads and protects sleep. New and unfamiliar material is placed Tuesday through Friday so there is still time to patch failures; consolidation and mixed retrieval are placed Saturday, when interleaving produces more durable retention than blocked practice. Sunday morning is deliberately empty: cramming immediately before an exam consumes the working memory that multi-step clinical reasoning requires, and with 200% time your constraint is cognitive stamina, not clock.
One limitation, stated plainly. This guide is built from the current NCLEX blueprint and 2024–2026 guidelines reconstructed against your two files. It will be strong on standard high-yield content and may miss course-specific quirks — an instructor's pet distinction, a textbook edition's idiosyncratic numbers, a lecture emphasis. Where this guide and your course materials disagree on a specific value or regimen, your course materials are the exam-correct answer. Note the divergence, learn both, and move on.
American College of Cardiology. (2025, October 1). High blood pressure focus of new ACC/AHA guideline. https://www.acc.org/latest-in-cardiology/articles/2025/10/01/01/new-in-clinical-guidance-hbp
American Heart Association. (2025). 2025 high blood pressure guideline: Top things to know. Professional Heart Daily. https://professional.heart.org/en/science-news/2025-high-blood-pressure-guideline/top-things-to-know
Cardi-OH. (2025). 2025 ACC/AHA guideline for high blood pressure in adults. https://www.cardi-oh.org/resources/current-57--2025-accaha-guideline-for-high-blood-pressure-in-adults
Guideline Central. (2024). ACG Helicobacter pylori infection clinical guideline summary 2024. https://www.guidelinecentral.com/guideline/13288/
Guideline Central. (2024). 2024 KDIGO chronic kidney disease clinical guidelines summary. https://www.guidelinecentral.com/guideline/25092/
Guideline Central. (2026, February). New 2026 AHA/ASA acute ischemic stroke guideline update. https://www.guidelinecentral.com/insights/feb-2026-ahaasa-earlymanagementacuteischemicstroke-guideline-spotlight/
Kidney Disease: Improving Global Outcomes. (2024). KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease: Executive summary. https://kdigo.org/wp-content/uploads/2017/02/KDIGO-2024-CKD-Guideline-Executive-Summary.pdf
Prabhakaran, S., Gonzalez, N. R., Zachrison, K. S., et al. (2026). 2026 guideline for the early management of patients with acute ischemic stroke: A guideline from the American Heart Association/American Stroke Association. Stroke. https://www.ahajournals.org/doi/10.1161/STR.0000000000000513
TCTMD. (2025, October 3). ACC updates HFrEF decision pathway, reinforcing the four pillars of therapy. https://www.tctmd.com/news/acc-updates-hfref-decision-pathway-reinforcing-four-pillars-therapy
University of Illinois Chicago Drug Information Group. (2025, January). What are the latest guideline recommendations for the treatment of Helicobacter pylori infection in the U.S.? https://dig.pharmacy.uic.edu/faqs/2025-2/january-2025-faqs/
University of Minnesota College of Pharmacy. (2024). 2024 American College of Gastroenterology H. pylori guidelines. https://www.pharmacy.umn.edu/2024-american-college-gastroenterology-h-pylori-guidelines
U.S. Pharmacist. (2025, December 12). Updated guidance on diagnosing and treating Helicobacter pylori infection. https://www.uspharmacist.com/article/updated-guidance-on-diagnosing-and-treating-helicobacter-pylori-infection